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Abstract 
Roles of transcription factor T-bet in memory CD4+ T cell generation, function, homeostasis and 
tissue targeting 
Jun-Kui Chen
Memory T cells are a critical component of immunological memory, which provides 
long-lasting immunological protection. These cells are characterized by a lower response 
threshold, rapid effector cytokine production, and prolonged longevity, and thus allow organisms 
to respond to pathogens more rapidly and effectively. However, the mechanisms that regulate the 
generation, function, homeostasis and tissue targeting of memory CD4+ T cells are not clear.  
This body of work investigated post-effector requirement for T-bet expression in 
determining the circulating and tissue resident memory CD4+ T cell fate and the implications of 
early T-bet deletion on lung CD4+ TRM development. We used mouse models with conditional 
expression of T-bet to delete T-bet in CD4+ T cells after priming and effector differentiation to 
analyze the development of resultant memory CD4+ T cells. We found that T-bet-ablation 
following cell priming and Th1 polarization did not impair the ability of Th1 effector cells to 
produce high levels of IFN-γ production, and moreover, there were dramatic increases in IL-2 
production, suggesting post-effector T-bet expression is not required for functional maintenance 
in effector cells. Memory CD4+ T cells that developed from T-bet ablated effector cells after 
transfer to lymphocyte deficient RAG1/2-/- hosts or intact congenic hosts had increased 
persistence, and they maintained lower but substantial levels of IFN-γ and higher IL-2 
production. We found elevation of IL-17 production and RORγt expression in T-bet ablated 
memory CD4+ T cells, and transcriptome analysis further showed that these cells upregulated 
genes expressed by other CD4+ T cell subsets, including Foxp3 and GATA3, indicating greater 
functional plasticity of T-bet-ablated memory CD4+ T cells. Increased localization of T-bet-
ablated memory CD4+ T cells in the lung resident niche was found only in RAG1/2-/- hosts but 
not in congenic hosts, indicating the importance of the tissue environment in the development of 
TRM cells.  
Using antigen specific T-bet+/- OT-II and T-bet-/- OT-II cells, we found that T-bet+/- OT-II 
cells had increased persistence while T-bet-/- OT-II cells had decreased persistence compared 
with the wild type OT-II cells after PR8-OVA influenza virus infection. However, both T-bet+/- 
and T-bet-/- OT-II cells had normal TRM formation.  
Collectively, our results reveal the roles of T-bet in regulating the generation, function, 
maintenance and tissue targeting of memory CD4+ T cells. 
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CHAPTER 1: Introduction 
Section 1.1: Overview of adaptive immunity 
The human body is constantly exposed to assaults from a variety of environmental 
pathogens. When infection occurs, our immune system reacts by invoking multiple mechanisms 
to eliminate the pathogens. The immune response against pathogens involves two systems: 
innate immunity, which is the first line of defense; and adaptive immunity, which provides 
immunological memory and long-lasting protection against previously encountered pathogens.   
When pathogens breach anatomical barriers of hosts, the innate immune response is 
initiated immediately. Innate immunity uses anti-microbial enzymes, antimicrobial peptides and 
complement system present in blood and extracellular fluid to kill and contain the effect of 
pathogens. It also involves a system of pathogen-associated molecular patterns (PAMPs) 
expressed by phagocytic cells to recognize the host and a wide range of pathogens. Following 
this initial response, the adaptive immune response are initiated. In contrast to the rapid and 
nonspecific response of innate immunity, adaptive immunity is characterized by its delayed and 
highly specific immune response. Adaptive immunity results in the expansion of antigen-specific 
lymphocytes recognizing specific pathogen epitopes and the formation of immunological 
memory, which can provide long-term protection and generate rapid and robust response upon 
repeat encounters with the same pathogen. 
The main cell types involved in adaptive immunity are B and T lymphocytes. Both B and 
T cells recognize antigens through surface antigen-specific receptors, which are products of gene 
segment rearrangements. The diversity in the antigen-specific receptors allow B and T cells to 
recognize numerous and diverse antigens, protecting the host from a wide array of pathogens.  
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The T cell immune response can be characterized by three phases: activation and clonal 
expansion, contraction of effector T cells, and memory formation (Figure 1.1). Upon antigen 
engagement in secondary lymphoid tissues, antigen-specific naïve T cells recognize their specific 
antigens in the context of MHC presenting on the surface of antigen presenting cells (APCs). 
Antigen-specific naïve T cells then undergo clonal expansion and cell differentiation to generate 
a large population of multifunctional and heterogeneous effector cells.  Different functional 
classes of effector T cells are specialized for different activities. Naïve CD8+ T cells recognize 
antigens displayed on MHC class I and differentiate into cytotoxic effector T cells that can kill 
infected cells. CD4+ T cells have more flexibility in effector cell differentiation. After 
recognition of antigens displayed on MHC class II, naïve CD4+ T cells can differentiate into a 
variety of CD4+ effector subsets, including TH1, TH2, TH17, Treg and TFH cells (1).  
Following clearance of the pathogens, effector T cells undergo a contraction phase during 
which most of the effector T cells die. However, a small subset of antigen-experienced effector T 
cells survive and persist as memory T cells, which can generate a robust and rapid functional 
response upon encountering the same antigens. Memory T cells persist with longevity and 
heterogeneity in multiple sites. However, the mechanisms by which memory T cells are 
generated and maintained remain unresolved issues in the field. Our studies explore the signaling 
pathways, especially transcriptional control in the memory T cell development.  
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Figure 1.1: Kinetics of adaptive immunity 
T cell adaptive immunity is initiated when T cells encounter their specific antigens 
presented by antigen presenting cells. The immune response is characterized by following three 
phases: activation and expansion, contraction, and memory. During the activation and expansion 
phase, antigen-specific T cells proliferate rapidly and extensively and differentiate into different 
types of effector cells, generating a larger effector cell pool with diverse functions. Following 
pathogen clearance, the majority of effector T cells die during contraction phase. However, a 
small portion of effector T cells survive the contraction phase and become long-lived memory T 
cells which can induce robust and rapid immune response upon encountering the same antigens. 
Number of T cells (black) and pathogen load (red) are indicated in the graph. 
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Section 1.2: T cell activation 
1.2.1 T cell priming and activation 
Naïve T cells circulate from bloodstream to secondary lymphoid organs (SLOs) and back 
to bloodstream (2).  This circulation route allows naïve T cells to survey thousands of DCs for 
antigens that are specifically recognized by them. Naïve T cells in the blood enter SLOs through 
specialized high endothelial venules (HEVs), where naïve T cells bind to endothelium cells 
through cell-cell interaction via cell-adhesion molecules and are empowered with capacities to 
cross the endothelium barriers. Lymphocyte entry to SLOs occurs in distinct stages. Naïve T 
cells first tether and roll on the wall of HEVs through the short-term interaction of L-selectin 
CD62L expressed on the surface of naïve T cells with its ligand peripheral node addression 
(PNAd) that are expressed on the surface of enthothelial cells of HEVs (3). The rolling of naïve 
T cells on the wall of HEVs enables the sampling of chemokines bound to the surface of HEVs. 
For example, the chemokine receptor CCR7 on naïve T cells engages with its ligand CCL21 on 
HEVs (4), which leads to the upregulation and activation of the integrin such as lymphocyte 
function-associated antigen 1 (LFA1). Activated LFA1 binds tightly to intercellular adhesion 
molecule 1 (ICAM-1), which facilitates firm adhesion of T cells on HEVs and transmigration of 
T cells into the SLOs (5, 6). Upon entering the lymph nodes, naïve T cells begin to scan the 
surface of mature DCs. Those T cells that do not encounter their specific antigens exit the lymph 
node through efferent lymphatic vessels. However, those naïve T cells that encounter their 
specific antigens become activated and start to proliferate and differentiate to generate effector T 
cells. 
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TCR stimulation plays a central role in T cell activation and memory development. It has 
been shown that strong TCR stimulation promotes T cell expansion (7) and the strength of TCR 
stimulation would affect the functions of effector cells and the differentiation program towards 
effector and memory T cells (8, 9). The TCR comprises a heterodimer that consists of one α-
chain and one β-chain, which together form the binding domain for interaction with specific 
peptide-MHC complexes. The αβ heterodimers are coupled with the CD3 protein complex 
consists of ε, γ and δ chains and ζ chains. The stable engagement of TCR with peptide-MHC 
complexes requires the assistance of co-receptors CD4+ and CD8+ which bind to cell surface 
MHC class II and MHC class I respectively. When T cell receptors and co-receptors bind to 
peptide-MHC complexes, the co-receptor associated kinase LCK phosphorylates the 
immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic domain of CD3 
subunits and ζ chains, which recruit and activate tyrosine kinase ZAP-70. Activated ZAP-70 
phosphorylates the scaffold protein LAT and another adaptor protein SLP-76. Phosphorylated 
LAT recruits many signaling molecules to form a complex called LAT signalosome, which 
includes SLP-76, PLC-γ, GADS, ADAP, and GRB2 (10). The activation of PLC-γ leads to the 
breakdown of membrane lipid PIP2 and generation of diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3). IP3 facilitates the Ca2+ influx from endoplasmic reticulum to cytosol, and 
elevated level of cytoplasmic Ca2+ leads to the activation of transcription factor NFAT. Signaling 
through DAG leads to the activation of PKC-θ and MAP kinase (MAPK), which ultimately 
results in the activation of transcription factors NFκB and AP-1 respectively (10). Transcription 
factors NFAT, NFκB  and AP-1 promote gene transcription, resulting in cell proliferation and 
differentiation. 
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Although TCR signaling is essential for T cell priming, the optimal activation of T cells 
requires two additional signals: co-stimulatory signals and cytokines (Figure 1.2). Without co-
stimulatory signals, TCR signaling alone will result in cell anergy, a state in which T cells 
exhibit hyporesponsiveness to subsequent activation and are impaired in IL-2 production and cell 
proliferation (11). The major co-stimulatory receptor required for naïve T cell activation is CD28 
(12).  CD28 promotes cell cycle progression, cell survival and differentiation. Engagement of 
CD28 with its ligand B7(CD80/86) would lower the threshold of T cell activation, increasing the 
sensitivity of T cells to antigen stimulation (13). During T cell activation, IL-2 is important for 
cell proliferation and differentiation. CD28 signaling greatly increases IL-2 production at both 
transcriptional and post-transcriptional levels (14). CD28 signaling activates PI 3-kinase and 
subsequent PLC-γ, which ultimately leads to the activation of transcription factors NFAT, NFκB 
and AP1. These transcription factors enhance the transcription of IL-2 mRNA. At the post-
transcriptional level, CD28 signaling stabilizes the IL-2 mRNA by inducing the expression of 
NF90 which binds to the AU-rich region that regulates the degradation of mRNA (15, 16). 
In addition to the TCR signaling and the costimulatory signals, cytokines are the third 
signal that are essential for programming T cells into fully functional effector cells. For CD8+ T 
cells, signal 3 is predominantly from IL-12 and type I IFNs, which can promote proliferation and 
survival of activated CD8+ T cells, and enhance the functionality by increasing the IFN-γ 
expression (17). For CD4+ T cells, various cytokines produced by antigen presenting cells 
depending on the pathogens they encounter would provide different types of signal 3 that would 
result in the development of different types of effector cells, including Th1, Th2, Th17, Tfh, and 
Treg cells. 
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Figure 1.2 The three signals required for T-cell activation 
Engagement of peptide-MHC complexes with TCR delivers signal 1 and initiates T cell 
activation. However, this signal alone is not sufficient for optimal T cell activation. Naïve T cells 
require additional signals to proliferate and differentiate into effector T cells. Co-stimulatory 
signal (signal 2) mediates by CD28 binding to its ligand B7 (CD80/86) on APC. Signal 3 is 
delivered through cytokines produced by APCs, and it significantly regulates cell differentiation 




Section 1.3: T cell differentiation and transcriptional regulators 
Section 1.3.1: CD8+ T cell differentiation and transcriptional regulators 
An effective adaptive immune response relies on functions of resultant effector cells. 
CD4+ and CD8+ T cells undergo distinct differentiation pathways generating functional subsets 
of effector cells. CD8+ T cells differentiate into cytotoxic T cells, also known as cytotoxic 
lymphocytes or CTLs, which are important in clearance of virally infected cells. CTLs use 
mainly use two contact-dependent strategies, the granule- and FAS-mediated pathways, for the 
destruction and killing of target cells (18). Upon engagement with infected cells, CTLs release 
cytotoxic granules containing perforin, granzymes and granulysin, which together induce 
apoptosis in target cells. Binding of the FAS ligand on CTLs with the death receptor FAS 
activates caspase-8, leading to the downstream activation of apoptosis pathways (18). CTLs also 
secrete high levels of effector cytokines like TNF and IFN-γ to exert cytotoxic functions on the 
target cells and promote inflammation. 
Transcription factors play critical roles in CD8+ T cell differentiation. Within the 
transcription factor sets of CD8+ T cells, T-bet and eomesodermin (EOMES), which are 
members of T-box transcription factors, have been intensively studied. Initially, it was shown 
that IFN-γ production was dramatically decreased by T-bet-deficient CD4+ T cells, however T-
bet-deficient CD8+ T cells could still maintain normal level of IFN-γ production and cytolytic 
function (19), which implies a T-bet independent mechanism in effector function of CD8+ T 
cells.  Later it was found that EOMES and T-bet cooperate by partially redundant functions to 
induce IFN-γ and granzyme B (20). However, CD8+ T cells lacking both T-bet and EOMES lose 
their cytotoxicity and differentiate into IL-17-producing CD8+ T cells accompanied by severe 
inflammatory syndrome and neutrophil infiltration (21). T-bet expression is induced rapidly by 
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TCR signaling and further augmented by IL-12 signaling, and it is required for early production 
of IFN-γ by CD8+ T cells (22, 23). However, EOMES expression is induced later in a RUNX3-
dependent manner and is augmented by IL-2 signaling, but repressed by IL-12 signaling, and it is 
engaged in sustaining late phase IFN-γ production and perforin activation (22-24). 
T-bet and EOMES have reciprocal expression in regulating the effector and memory
development. Inflammatory signals presented during CD8+ T cell priming create a gradient of T-
bet in which high T-bet expression promotes short-lived effector cells (SLECs) while low T-bet 
expression promotes memory precursor effector cells (MPECs). By contrast, Eomes-deficient 
effector CD8+ T cells can still generate normal level of SLECs and MPECs similar to the wild 
type, but have impaired CD8+ T cell homeostatic proliferation and long-term persistence (25). 
Section 1.3.2: CD4+ T cell differentiation and transcriptional master regulators 
Compared with CD8+ T cells, CD4+ T cell differentiation pathways are more diverse. 
Depending on the pathogens encountered by APCs and the cytokines secreted by APCs as well 
as other innate immune cells, CD4+ T cells can differentiate into functionally distinct types of 
effector cells. 
Th1 cells and the master regulator T-bet 
The initial finding of distinct CD4+ T effector cell subsets was from the work of 
Mosmann & Coffman (26). They showed that CD4+ T cells could be divided into two groups, 
Th1 cells that made IFN-γ and Th2 cells that made IL-4 (26). Th1 cells are important for the 
clearance of intracellular pathogens (27, 28). IFN-γ secreted by Th1 cells can activate 
macrophages for the antimicrobial activity to kill ingested pathogens (29). 
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T-bet is the master regulator for Th1 cells, and it is upregulated during Th1
differentiation and accounts for the expression of IFN-γ. T-bet-deficient cells are impaired in 
Th1 differentiation and IFN-γ production and they could not initiate effective Th1 response to 
control the infection by Leishmania major and Mycobacterium tuberculosis (19, 30). T-bet 
deficiency is strongly related to asthma-like syndrome both in mice and human. T-bet-/- 
spontaneously develop asthma-like diseases and there are significantly reduced number of T-bet 
expressing CD4+ T cells in human asthmatic airways (31). IFN-γ, IL-12 and T-bet cooperatively 
form positive feedback loop to sustain T-bet expression and promote Th1 differentiation. T-bet is 
not expressed in naïve CD4+ T cells. The presence of IFN-γ and IL-12 in the microenvironment 
is critical for Th1 differentiation. IL-12 induces IFN-γ production from other innate immune 
cells, especially NK cells. TCR and IFN-γ-STAT1 signaling initiates T-bet expression, which is 
independent of IL-12 signaling as TCR-mediated signaling inhibits IL-12Rβ2 subunit expression 
(32, 33). Induction of T-bet in turn also promotes IFN-γ production, which forms a positive 
feedback loop. Termination of TCR and IL-2 signaling induces IL-12Rβ2 subunit expression, 
thus promoting IL-12-STAT4 signaling, which drives the second wave of T-bet expression and 
stabilizes Th1 cell differentiation (32, 34). 
T-bet is also involved in the chromatin remodeling of genes, especially in Ifng locus (35).
T-bet binds to the Ifng promoter and multiple regulatory sites to directly activate Ifng gene (36-
38). T-bet mediated transcription of Ifng is amplified by additional transcription factors HLX and 
RUNX3, both of which are induced by T-bet during Th1 differentiation (39, 40).  T-bet also 
enhances Th1 lineage commitment by repressing the induction and activities of other master 
regulators of Th cell fate, such as GATA3, Bcl-6, and RORγt (41). 
Th2 cells and the master regulator GATA3 
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Th2 cells are important for controlling extracellular parasite infections including 
helminths and they also play important roles in the development of asthma and other allergic 
inflammatory diseases. The function of Th2 cells is associated with the cytokines they produce, 
including IL-4, IL-5, IL-9, L-13 and IL-25. IL-4 is essential for Th2 cell development (42, 43). 
IL-4 signals through STAT6, which further promotes the expression of transcription factor 
GATA3. GATA3 is the master transcription factor that drives the differentiation of Th2 cells and 
promotes the cytokine expression, especially IL-4. Therefore, IL-4 signaling provides a positive 
feedback loop to sustain Th2 differentiation and the production of itself.  IL-4 also regulates B 
cell class switching to the IgE isotype, which mediates asthma and allergic symptoms (44). IgE 
binds and cross-links FcεRI receptors on basophils and mast cells, leading to cell activation and 
promoting the secretion of active products including histamine, serotonin and cytokines. 
GATA3 was the first transcription factor to be recognized as the master transcription 
factor for establishing a specific CD4+ T cell lineage (45, 46). GATA3 is expressed in a low but 
detectable level in naïve CD4+ T cells, but it is rapidly induced by IL-4 in a STAT6 dependent 
manner (47). In vitro data show that STAT6 activation is sufficient to induce high expression of 
GATA3 (48, 49). Ectopic expression of GATA3 in Th1 cells by retrovirus induces IL-4 
production (47). Without the presence of GATA3, Th2 differentiation is greatly inhibited both in 
vitro and in vivo (50, 51).  Conditional deletion of GATA3 completely blocks the IL-5 and IL-13 
expression but does not impair IL-4 production (50), which is reminiscent of GATA3 in IL-4 
locus chromatin remodeling (52-54) and the binding of GATA3 to the promoters of IL-5 and IL-
13. GATA3 promotes Th2 differentiation by induction of Th2 cytokine, selective growth of Th2 
cells, and inhibition of Th1-specific factors (55). 
Th17 cells and the master regulator RORγt 
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Th17 cells mediate the clearance of extracellular bacteria and fungi. Th17 cells can 
produce IL-17A, IL-17F, IL-17A/F heterodimers, IL21 and IL-22. IL-17 has powerful effects on 
stromal cells, inducing the inflammatory cytokine expression and the recruitment and activation 
of neutrophils. Initially, IL-23 was found to be required for Th17 differentiation (56-58), 
however, later studies show that Th17 cells can be induced from naïve CD4+ T cells by the TCR 
stimulation in the presence of IL-6 and TGFβ independent of IL-23 (59-61). Therefore, IL-23 
may be essential for maintaining Th17 function and/or promoting survival of these cells. 
Nonetheless, following TCR stimulation, IL-6 and TGFβ cooperatively induce transcription 
factor RORγt, which is the master regulator for Th17 cells (62). IL-21 can substitute for IL-6 and 
cooperate with TGFβ for the induction of RORγt and IL-17, serving as an alternative pathway 
for Th17 induction (63). Therefore, Th17 differentiation occurs in 3 stages: a differentiation 
stage by the action of IL-6 and TGFβ; an amplification stage regulated by IL-21; and a 
stabilization stage mediated by IL-23 (64). It should be noted that, STAT3, a signal transducer 
important for Th17 differentiation, can be activated by IL-6, IL-21, and IL-23. 
Ectopic expression of RORγt is sufficient to drive IL-17 expression and RORγt 
deficiency protects mice from experimental autoimmune encephalomyelitis (EAE) due to 
significantly lower IL-17 production. However, RORγt deficiency does not completely abolish 
IL-17 production or total protect mice from EAE, and residual effects are due to the activity of 
another orphan nuclear receptor, RORα (65). Deficiency in both RORγt and RORα completely 
abolish the Th17 differentiation and protect mice from EAE totally. 
Tfh cells and the master regulator Bcl-6 
A major function of CD4+ T cells in adaptive immunity is to help B cells make antibody. 
T follicular helper (Tfh) cells in germinal centers are specialized CD4+ T cells which provide 
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help to B cells for immunoglobulin class switching and somatic hypermutation. Tfh cells can be 
identified by the expression of the chemokine receptor CXCR5 and the inhibitory receptor PD-1. 
CXCR5 binds to its ligand chemokine CXCL13, produced by follicular stromal cells, leading to 
the recruitment of Tfh cells to the follicles.  Whether Tfh cells constitute an independent CD4+ T 
cell lineage remains unclear and a matter of debate in the field. Several studies reported that the 
transcription factor Bcl-6 is essential for Tfh differentiation but not required for the 
differentiation of other CD4+ T helper cell subsets (66-68). This finding provides evidence that 
Tfh cells represent an independent CD4+ T cell lineage. Cytokines IL-6 and IL-21 are important 
for Tfh cell differentiation. Loss of both cytokines signaling greatly impairs the Tfh development 
but loss of either IL-6 or IL-21 alone does not, indicating functional redundancy of IL-6 and IL-
21 (69). An important target of IL-6 and IL-21 signaling is STAT3. IL-21 is also expressed by 
Tfh cells. 
Bcl-6 deficiency inhibits T cell differentiation to Tfh cells and blocks germinal center 
reactions. Overexpression of Bcl-6 induces the expression of endogenous Bcl-6 (66) and Tfh 
specific molecules CXCR5, CXCR4, and PD-1 (68). Bcl-6 binds to the T-bet and RORγt 
promoters and represses IFN-γ and IL-17 production, thus ensuring Tfh cell lineage commitment 
(68). The transcription factor Blimp-1, which is an antagonist of Bcl-6, blocks Tfh differentiation 
(67). 
Treg cells and the master regulator Foxp3 
The different types of effector T cells described above are critical in pathogen clearance 
through cytokine production and activating responding cells. However, persistent immune 
responses may be harmful to the host and need to be regulated tightly. Treg cells play critical 
roles in the establishment of self-tolerance and the regulation of immune response. Treg cells are 
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grouped into two main subsets: those generated naturally in thymus (nTreg), and those induced 
in the periphery or cell culture (pTreg or iTreg). In 2003, Foxp3 was identified as the master 
transcription factor for nTreg cell differentiation (70, 71). Treg differentiation is also regulated 
by the cytokines in the environment. TGFβ is critical for iTreg differentiation by promoting the 
Foxp3 expression and thus converting the CD4+CD25-Foxp3- T cells into CD4+CD25+Foxp3+ T 
cells (72). Without the presence of other inflammatory cytokines, TGFβ alone can induce the 
differentiation of TCR stimulated CD4+ T cells into iTreg (59). TGFβ is also essential for nTreg 
development (73). In addition to TGFβ, IL-2 is also important for Treg development (74). IL-2-
dependent STAT5 activation induces Foxp3 expression and thus promoting Treg differentiation 
(75). Treg cells can produce TGFβ, IL-10, and IL-35, each of which can contribute to the 
immune suppressive activity by Treg cells. 
Foxp3 is essential for Treg cell differentiation. Patients with human immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome have mutations in 
Foxp3 gene, and the Scurfy mouse model with multi-organ infiltration also lacks Foxp3 
expression (76-78). Foxp3 is highly expressed in naturally arising CD4+CD25+ Treg cells, and is 
important for CD4+CD25+ Treg cell development (70). Ectopic expression of Foxp3 confers the 
CD4+CD25- T cells with suppressor function (70, 71). Continued Foxp3 presence is required to 
maintain the transcriptional and functional programs of Treg cells (79). 
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Figure 1.3: CD4+ T cell differentiation and effector lineages 
CD4+ T cells are important for effective and optimal adaptive immune responses. 
Infections with different pathogens result in different environments and cytokines that in term 
lead to the differentiation and generation of various CD4+ effector T cells. Intracellular bacteria 
and virus infection induces the production of IFN-γ and IL-12, which lead to the initiation of Th1 
differentiation. IFN-γ and IL-12 activates STAT1 and STAT4, which further promotes the 
expression of master transcription factor T-bet, leading to the establishment of Th1 lineage and 
the promoting the expression of effector cytokines IFN-γ. Parasite infection results in the 
increased secretion of IL-4 by innate cells and activation of STAT6 and master transcription 
factor GATA3, inducing the differentiation of Th2 cells. Effector cytokines IL-4, IL-5 and IL-13 
are produced by Th2 cells. Extracellular bacteria and fungi infection induces the production of 
TGF-β, IL-6 and IL-23, which leads to the activation of STAT3 and the master transcription 
factor RORγt, promoting the establishment of Th17 cells. Tfh cells in germinal centers are 
important in providing help for B cell to make antibodies. Bcl-6 is the key transcription factor for 
Tfh cell differentiation. Treg cells are important in controlling the immune responses. TGF-β and 
IL-2 are critical for the induction of master transcription factor Foxp3 and therefore the 
differentiation of Treg cells. 
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Section 1.3.3: T-bet mediated transcriptional regulation and lineage suppression 
T-bet mediated transcriptional regulation
T-bet belongs to the T-box transcription factor family with a specific T-box DNA-
binding domain. A consensus T-box binding site was identified in early studies and was found in 
human and murine IL-2 and IFN-γ promoter regions (80). Using chromatin immunoprecipitation 
followed by deep sequencing techniques (ChIP-Seq), a more precise T-bet binding motif has 
been revealed (81). Within the human genome, a total of 15,175 T-bet binding sites have been 
identified, with 12% of these binding sites located in the promoter regions of known genes and 
88% in the distal region (> 2 kb to gene promoters) (81). Among the genes bound by T-bet, a 
large proportion of them are involved in the immune response and transcriptional regulation and 
these immune regulatory genes are enriched for T-bet distal binding sites, which show markers 
of enhancers and promote gene expression (81).  In mouse Th1 cells, 2,493 genes were found to 
be bound by T-bet (82). Therefore, T-bet is able to bind to and mediate a broad range of genes 
expressed within the cell.
However, the binding of T-bet and other T-box transcription factors to DNA does not 
necessarily result in gene expression changes (83), indicating that other regulatory mechanisms 
may be involved.  For example, multiple studies have shown a correlation between the presence 
of T-bet and chromatin modifications in T-bet target genes (84, 85). T-bet mediates epigenetic 
modifications by physically interacting with H3K4me2-methyltransferase complex to induce  
permissive H3K4me2 marks and with H3K27-demethylase complex to remove repressive 
H3K27me3 marks at target genes (84). T-bet also induces H3K9-acetylation in target gene 
promoters to promote gene expression (83). Therefore, CD4+ T cells cultured in Th1 polarizing 
conditions show increased permissive H3K4me1 marks in genes that are positively regulated by 
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T-bet and increased repressive H3K27me3 marks in genes that are negatively regulated by T-bet 
(81, 82). 
Ifng is a critical gene regulated by T-bet. During Th1 differentiation, T-bet directly binds 
to the promoter and distal regulatory sites of the Ifng gene, promoting Ifng transcription (81). T-
bet is also involved in the chromatin remodeling of the Ifng locus. T-bet binding sites are often 
coincident with DNaseI hypersensitive sites (DHS) and are also accompanied by epigenetic 
modifications, like increased permissive H3K4me1 marks (81, 82). Nonetheless, T-bet mediated 
transcription of Ifng gene is amplified by additional transcription factors HLX and RUNX3, both 
of which are induced by T-bet during Th1 differentiation (39, 40). T-bet and RUNX3 
cooperatively bind to the promoter of the Ifng gene to enhance Ifng transcription (40). 
Despite the roles of T-bet in activating a broad range of genes, whether T-bet can 
autoactivate the Tbx21 gene is not clear. Extensive distal T-bet binding in Tbx21 sites has been 
observed and these binding sites are accompanied by DHS and permissive H3K4me1 marks (81). 
It has also been shown that ectopic T-bet expression induces increased endogenous Tbx21 
transcript levels (35, 81), indicating that T-bet may be involved in the autoactivation of Tbx21 
gene. However, studies using T-bet-ZsGreen reporter mice show that T-bet is not required for its 
own induction in the presence of IL-12 and IFN-γ, although it may be involved in the direct 
activation of its own gene when induced by the IL-12- and IFN-γ-independent pathways (82).  
T-bet mediated lineage repression
T-bet is not only involved in the establishment of Th1 lineage by activating Th1 specific
genes, but also inhibits the induction of other CD4+ T cell lineages by suppressing the activities 
of critical molecules (41). GATA3 is the master transcriptional regulator for Th2 cells. During 
Th1 differentiation, early TCR signaling induces T-bet expression and T-bet is further 
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phosphorylated at Tyr525 by IL-2-inducible T cell kinase (ITK), which mediates the physical 
interaction between T-bet and GATA3 and thus sequesters GATA3 away from its binding sites 
in Th2 specific genes (86). Nonetheless, the interaction between T-bet and GATA3 redistributes 
GATA3 to T-bet binding sites at Th1 specific genes (81). T-bet and RUNX3 not only 
cooperatively promote Ifng gene transcription, but they also inhibit Il4 expression by binding to 
the Il4 silencer (40). Moreover, T-bet also binds to the Gata3 locus and induces the upregulation 
of repressive H3K27me3 marks, which inhibits GATA3 expression (82). Collectively, T-bet 
inhibits Th2 development by physically interacting with GATA3, redistributing GATA3 to T-bet 
binding sites in Th1 specific genes, inducing repressive histone marks, and cooperating with 
RUNX3 to suppress Il4 expression. 
T-bet inhibits Th17 cell differentiation by interacting with RUNX1 via T-bet Tyr304
position and therefore interfering with RUNX1-mediated Rorc transcription, resulting in the 
blockade of the expression of Th17 master transcription factor RORγt (87). During the early 
steps of Th1 cell differentiation, IL-12-dependent signaling through STAT4 polarizes activated 
CD4+ T cells into a transient state of Tfh cell-like Th1 cells, by increasing the expression of IFN-
γ and T-bet, the signature cytokine and transcription factor of Th1 cells, and IL-21 and Bcl-6, the 
signature cytokine and transcription factor of Tfh cells (88). However, these Tfh cell-like 
properties are not maintained long term. In later phases of Th1 differentiation, STAT4 signaling 
further increases T-bet expression, which represses Bcl6 expression and Tfh cell development 
(88). Bcl-6 is also a transcriptional repressor. It has been shown that T-bet physically interacts with 
Bcl-6 and redistributes it to the promoters of genes that are downregulated by T-bet in Th1 cells 
(89). Despite direct Bcl-6 regulation, IL-2 also adds another level in determining the Th1 and 
Tfh cell fate. In effector Th1 cells, high concentration of IL-2 inhibits BCL-6 expression, 
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resulting in a high ratio of T-bet to Bcl-6 and promoting the formation of the T-bet-Bcl-6 complex, 
which masks the Bcl-6 DNA-binding domain and therefore prevents Bcl-6 from repressing its 
target genes (90). In contrast, low concentration of IL-2 increases the ratio of Bcl-6 to T-bet, 
allowing excess Bcl-6 to inhibit its target gene Prdm1 which encodes transcription repressor 
Blimp-1 (90). Therefore, suppression of Blimp-1 by excess Bcl-6 increases  expression of Tfh 
signature genes that were previously suppressed by Blimp-1 (90). 
Collectively, the establishment of Th1 lineage not only requires T-bet mediated 
activation of Th1 specific genes, but it also requires T-bet mediated suppression of other genes 
at the same time. 
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Section 1.3.4: Plasticity of CD4+ T cell lineages 
It is now clear that differentiated cells still retain flexibility to be reprogrammed. 
Likewise, fully differentiated effector CD4+ T cell lineages also maintain flexibility to produce 
cytokines of other lineages according to the altered signaling contexts. Many signals are involved 
in the differentiation of CD4+ T cells, including the extracellular cytokine cues and the 
intracellular transcriptional events. These signals are also involved in the reprogramming and 
plasticity of CD4+ T cell lineages.  
Cytokines play very critical roles in the differentiation of CD4+ T cell lineages and in the 
induction of opposing CD4+ T cell lineages. Polarizing cytokines regulate the CD4+ T cell 
differentiation by binding to the respective cytokine receptors and inducing the signaling 
pathways that lead to the activation of certain JAK-STAT proteins, which results in the 
translocation of STATs into nucleus and thus increased transcriptional activities of their binding 
genes. It’s been shown previously that IL-12 and IL-4 are the defining cytokines that drive the 
differentiation of Th1 and Th2 cells.  When differentiated Th1 cells are cultured with IL-4, they 
are converted to be IL-4 producers and have significantly decreased ability to produce IFN-γ 
(91). In vivo helminth infection also repolarizes Th1 cells to acquire the ability of IL-4 
expression and lose the expression of IFN-γ (92).  IL-12, IFN-γ and type I IFNs are essential in 
repolarizing Th2 cells to produce IFN-γ during LCMV infection (93). Therefore, cytokines that 
drive the differentiation of one CD4+ T cell lineage could also drive the reprogramming of the 
other CD4+ T cell lineages.  Th17 cells can be repolarized to produce IFN-γ in the presence of 
IL-12 or IL-23, both of which activate STAT4 that is essential for Th1 differentiation (94-96). In 
vivo helminth infection also reprogram Th17 cells to produce IL-4 and lose the expression of IL-
17A (92). Tfh cells repolarized in Th1-, Th2-, and Th17-conditions acquire the ability to produce 
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IFN-γ, IL-4, and IL-17 respectively, whereas Th1, Th2 and Th17 cells repolarized in Tfh 
conditions acquire the ability to produce IL-21 and express CXCR5 and PD-1 (97). 
In addition to polarizing cytokines, expression level changes in master transcription 
factors also reprograms the cell polarization. It has been shown that overexpression of T-bet in 
fully differentiated Th2 cells empowers these cells to produce IFN-γ while suppressing the IL-4 
production (80). Similarly, overexpression of GATA3 in Th1 cells promotes IL-4 production 
(47). Not only overexpression of master transcription factors would reprogram differentiated 
CD4+ T cells, but downregulation of master transcription factors also repolarizes differentiated 
CD4+ T cells. Deletion of Foxp3 allele in mature Treg cells leads to deregulation of Treg 
transcriptional program, loss of suppressive function, and production of large amounts of IL-2 
and Th1 cytokines (79). A substantial subset of so called “ex-Foxp3” cells, which have lost 
previously-expressed Foxp3, have activated-memory phenotype and produce inflammatory 
cytokines IFN-γ and IL-17 (98). Nonetheless, conditional deletion of GATA3 from mature Th2 
cells would promote Th1 differentiation without the presence of Th1 inducing factors IL-12 and 
INF-γ (50) 
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Section 1.4: Memory T generation and maintenance 
Section 1.4.1: Generation of memory T cells 
After antigen engagement, naïve T cells proliferate and undergo extensive clonal 
expansion, resulting in up to 15-20 divisions and a 50,000-fold increase in number (17). Upon 
pathogen clearance, about 90% - 95% of effector T cells undergo apoptosis in the subsequent 
contraction phase, with only a small fraction of previously-activated T cells eventually becoming 
long-lived memory T cells. However, the mechanisms underlying memory T cell generation in 
terms of the signals that distinguish effector cells and memory cells still remain elusive and is a 
goal of the studies in this thesis. 
During the differentiation of CD8+ T cells at the peak of immune response, a 
heterogeneous pool of CD8+ T cells with different function and memory cell generation potential 
is generated. Within this heterogeneous CD8+ T cell pool, the short-lived effector cells (SLECs) 
(KLRG1hi IL-7Rαlo) are the terminally differentiated effector cells that would ultimately go 
through cell death during contraction phase; while the memory precursor effector cells (MPECs) 
(KLRG1lo IL-7Rαhi) have the potential to generate long-lived memory cells. The relative ratio of 
these two populations will change according to the signals by altering inflammation and effector 
receptors, IL-2 signaling, and transcriptional regulation, indicating that effector and memory fate 
of CD8+ T cells are determined during cell priming and expansion.  Unlike CD8+ T cells, CD4+ 
T cells do not have defining markers to identify effector and memory precursors. However, there 
are some common factors involved in the regulation of both CD4+ and CD8+ T cell memory 
generation. Previous studies have shown that T cell effector vs. memory fate is regulated by 
these two pathways: common gamma-chain cytokines (IL-2, IL-7 and IL-15), and the strength of 
antigenic and inflammatory signals (99). 
26 
IL-2 is important for driving effector and memory CD8+ T cell differentiation (100). 
Higher levels of IL-2 signaling promotes terminal differentiation of effector CD8+ T cells (24, 
101). By contrast, in CD4+ T cells,  increased responses to IL-2 promotes the generation of both 
effector and memory CD4+ T cells, as increased production of IL-2 during priming is associated 
with the decreased apoptosis of effector CD4+ T cells (102) and increased frequency of memory 
CD4+ T cells (103). Moreover, activated precursors of memory CD4+ T cells all upregulate 
CD25 (104, 105), a subunit of IL-2 receptor, while for CD8+ T cells, CD25 expression marks the 
different fates of becoming effector and memory cells (101). 
IL-7 and IL-15 are critical for both memory CD8+ and CD4+ T cell generation and 
homeostasis (106). CD8+ subsets with higher expression of IL-7 receptor alpha chain (IL-7Rα) 
are characterized as the memory precursors (107). However, IL-7 signaling does not directly 
relate to IL-7Rα expression since IL-7Rα expression and CD8+ T cell memory development do 
not change significantly in IL-7-/- mice (108). Furthermore, constitutive IL-7Rα expression does 
not affect the cell number or function of effector and memory CD8+ T cells generated, and it 
cannot rescue SLECs from death (109). Therefore, IL-7Rα serves as a phenotypic marker rather 
than a functional receptor when defining effector and memory CD8+ T cells. IL-7 is required for 
long-term maintenance of CD4+ T cells. However, there’s no evidence so far indicating IL-7R is 
a marker for effector or memory CD4+ T cells. IL-7R is downregulated after CD4+ T cell 
activation, but it can be upregulated during transition to memory CD4+ T cells (105).  
Nonetheless, constitutive expression of IL-7Rα does not change the kinetics of effector and 
memory development of CD4+ T cells (110), and limiting IL-7 level does not exacerbate  
CD4+ T cell contraction (111).  
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Signal strength during T cell priming is a critical factor in determining the fate of effector 
and memory T cells. Generally, there are three major classes of signals that regulate T cell 
activation and effector and memory T cell differentiation: signal 1 from antigens, signal 2 form 
co-stimulation, and signal 3 from inflammation. These three signals are closely linked during in 
vivo infection, and the strength of these signals would affect the function and fate of effector 
cells. The extent of CD8+ T cell clonal expansion is correlated with the abundance and affinity of 
antigens (112). Clonal expansion will be decreased when the strength of signals is limited by 
reducing the exposure to antigens and inflammation, shortening the duration of stimulation, or 
increasing intraclonal competition for signals. However, these strategies also enhance the 
formation of effector T cells with increased expression of IL-7R and lower expression of 
KLRG1, which is reminiscent of memory precursors (113-117). Inflammation signals sometimes 
are key factors for T cell fate determination. Increasing the amount of inflammation, when 
keeping the antigen level relatively constant would increase the proportion of terminally 
differentiated cells or SLECs (114, 115, 118); while deficiency of inflammation signals, like 
IFN-γ or IL-12, would increase the proportion of memory precursors or MPECs (118-120). 
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Section 1.4.2: Transcription factors in memory T cell development 
Cell fate decisions in effector and memory T cell generation are also regulated at the 
transcriptional level by different transcription factors. Several transcription factors regulating 
memory T cell development have been identified, and many function in pairs with differential 
expression. As previously discussed, T-box transcription factors T-bet and EOMES form such a 
pair. It was shown that higher expression of T-bet favors the development of KLRG1hi IL-7Rlo 
SLEC T cells, while lower T-bet expression promotes the development of KLRG1lo IL-7Rhi 
MPEC T cells (115). Interestingly, T-bet regulates the differentiation of SLEC and MPEC in a 
dose-dependent fashion with higher levels of T-bet in effector CD8+ T cells driving their 
terminal differentiation. During CD8+ T cell memory development, T-bet expression level 
progressively declines whereas EOMES expression increases (121). Therefore, the expression 
ratio of T-bet to EOMES would determine the phenotype, function, and cell fates, with highest 
T-bet/EOMES ratio at effector stage and lowest ratio in the memory stage. Many factors may be
involved in regulating T-bet and EOMES expression. Inflammatory cytokine IL-12 is apparently 
engaged in this process, since IL-12 drives T-bet and represses EOMES expression (23, 115). 
This reciprocal relationship also exists in other transcription factor pairs, including Blimp-1 & 
Bcl-6, ID2 & ID3, and STAT3 & STAT4 (112). 
Similar to CD8+ T cells, the differentiation of CD4+ effector and memory T cells also 
involves multiple transcription factors. The master transcription factors of each CD4+ T lineage, 
that is, T-bet, GATA3, RORγt, Foxp3, and Bcl-6, predominantly regulate the differentiation of 
each CD4+ lineage. However, the roles of these master transcription factors in CD4+ T cell 
memory development are not well understood. The role of T-bet in memory CD4+ T cell 
development was reported by Kaech et al (122). Using LCMV infection model and the 
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expression of two surface molecules, PSGL1 and Ly6C, they identified two subsets of cells, 
PSGL1hi Ly6Chi cells with higher T-bet expression and PSGL1hi Ly6Clo cells with intermediate 
T-bet expression. PSGL1hi Ly6Chi cells express higher levels of effector molecules, including
CXCR3, IFN-γ and granzyme B, compared to PSGL1hi Ly6Clo cells, and resemble the terminally 
differentiated effector cells. By contrast, PSGL1hi Ly6Clo cells express lower levels of effector 
molecules and have enhanced survival, high proliferative potential, and faster secondary 
responses, which are memory precursor-like properties. Downregulation of T-bet expression 
results in the increased frequency of PSGL1hi Ly6Clo memory precursors, which is similar to 
CD8+ T cells. Therefore, T-bet expression appears to balance the effector and memory 
differentiation in both CD4+ and CD8+ T cells. It’s not known whether other transcription factors 
that have been discussed in previous sections regulating CD8+ effector and memory T cell 
development are also involved in the memory CD4+ T cell generation.  
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Figure 1.4: Transcription factors driving memory T cells differentiation 
(Upper) Expression level of transcription factors would balance the differentiation 
potential of short-lived effector (SLEC) and long-lived memory precursor (MPEC) cells. Many 
transcription factors function as reciprocal pairs in regulating the SLEC and MPEC potential. 
Higher expression level of T-bet, Blimp-1, ID2, and STAT4 would promote SLEC 
differentiation, while higher expression level of EOMES, Bcl-6, ID3, and STAT3 would favor 
MPEC differentiation.  
(Lower) In CD4+ T cells, T-bet expression levels also modulate effector and memory T 
cell fate. Combined with the surface molecule PSGL1 and Ly6C, terminally differentiated 
effector and memory precursor cells are identified. PSGL1hi Ly6Clo T-betint cells have properties 
of memory precursors, and PSGL1hi Ly6Chi T-bethi have properties of terminally differentiated 
effector cells.  
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Section 1.4.3: Models of T cell diversification 
It has been well established that naïve T cells are able to give rise to heterogeneous 
memory T cells with different phenotype and functions. In mouse studies using single cell 
adoptive transfer and barcoding of single naïve T cells, it is shown that a single naïve T cell can 
give rise to multiple types of effector and memory T cells (123, 124). However, the mechanisms 
controlling memory generation and diversification remain elusive and a matter of debate in the 
field. Much work is needed to better understand how effector T cells are regulated to generate 
heterogeneous cells with different phenotypes, functions and effector and memory potential. 
Early studies suggested a divergent fate model in which memory T cells are generated in a 
distinct pathways from effector T cells after T cell activation (Figure 1.5A). Since then many 
other differentiation models have also been postulated (112).   
The decreasing-potential model (Figure 1.5B) suggests that repeated T cell stimulation 
with antigens and pro-inflammatory cytokines results in increased proliferation and promotes 
terminal differentiation. As the stimulation signals accumulate, T cells progress to a more 
differentiated state accompanied by a successive loss of properties associated with memory T 
cells, including enhanced longevity and proliferative capacity, but the effector functions are 
maintained. Thus, this model proposes a pathway to generate heterogeneous effector T cells 
pools with various degrees of differentiation based on the accumulated signals during infection. 
Data that support this model are from studies showing that reduced duration of antigen 
stimulation and lower inflammation signals results in the more rapid memory T cell formation 
(114, 119). Moreover, T cells that are stimulated later when antigen availability is reduced favors 
the formation of central memory (TCM)-like cells (125).  
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The signal strength model (Figure 1.5C) proposes that generation of heterogeneous 
effector T cells is the result of the combined signals from antigen, co-stimulation, and pro-
inflammatory cytokines encountered during early priming. A stronger signal promotes greater 
clonal expansion and generation of cells with greater memory potential, while excess signals 
would lead to terminal differentiation and cell death (126). Compared with the decreasing-
potential model, this model suggests that different T cell fates can be specified early during the 
priming depending on the signal intensity and these cells proceed divergently for further 
differentiation, rather than a linear differentiation with cumulative signals.   
The asymmetric cell fate model (Figure 1.5D) proposes that a single precursor T cell can 
generate both effector and memory T cells through asymmetric cell division, which occurs 
during clonal expansion of activated T cells (127). In this model, the daughter cell closer to the 
APC receive stronger TCR and co-stimulatory signals in addition to pro-inflammatory cytokine 
signals. The unequal partitioning of fate determinants through asymmetric division results in the 
generation of some T cells with more differentiation signals that eventually differentiate into 
terminal effector T cells, while other T cells receiving less differentiation signals remain less-
differentiated and have greater memory potential.  
The differentiation models proposed above are not mutually exclusive. Being confined to 
a single proposed model will oversimplify the real differentiation model. The complexity of 
infection and immune responses may require the existence and interaction of different 
differentiation models. Indeed, all these model generates a net result containing a heterogeneous 
resultant cells that have a gradient of differentiation states, at one end of which is the terminal 
effector cells and at the other end of which is long-lived memory precursors. This differentiation 
34 
gradient gives cells flexibility to tailor immune responses according to the identity and intensity 
of infection.  
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Figure 1.5: Models of T cell diversification 
Proposed models of T cell diversification to generate effector and memory T cells with 
various differentiation states. (A) The divergent fate model suggests that activated T cells give 
rise to effector and memory T cells in distinct pathways. (B) The decreasing-potential model 
proposes that T cells progress to more differentiated states with cumulative activation signals 
while losing memory potential along the way. (C) The signal-strength model suggests that 
overall signal strength at the early phase of T cell priming determines the differentiation states. 
Stronger signals promotes terminal differentiation, while weaker signals favors the generation of 
memory precursors. (D) The asymmetric sell fate model proposes that a single naïve T cells can 
give rise to effector and memory precursors by asymmetric cell division.  
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Section 1.4.4: Functional plasticity of memory T cells 
As discussed in previous sections, effector T cells, especially effector CD4+ T cells, have 
functional plasticity according to the environmental cues and transcriptional change. Memory 
CD4+ T cells also demonstrate functional plasticity. Our lab initially showed that antigen-
specific memory CD4+ T cells derived from IFN-γ producing effectors could produce 
predominantly either IFN-γ or IL-4 in response to different nature of TCR stimulus (128). 
Inflammation and cytokine environment can alter cytokine recall of memory CD4+ T cells. 
Human Th1-like effector memory T cells (TEM) stimulated under Th2 conditions produced IL-
4, while Th2-like TEM stimulated under Th1 conditions could not produce IFN-γ (129). In mice, 
pro-inflammatory cytokine environment favoring Th1 reaction is required for prompting Th1 
cytokines from Th2-derived memory T cells or uncommitted CD4+ TCM cells (130-132), while 
Th2 cytokine environment promotes Th2 cytokines from Th1-derived memory T cells (132). 
Interestingly, the continued presence of pro-inflammatory cytokine IL-12 was shown to be 
essential for inducing Th1 effector cytokines by CD4+ TCM cells derived from strong Th1 
primary immune response (131).  
In addition to environmental cues, transcription factors can also regulate functional 
plasticity of memory CD4+ T cells. Human Th1-like TEM  express high level of T-bet mRNA 
and Th2-like TEM express high level of GATA3 mRNA, which account for the polarized 
cytokine expression of these two subsets (129). However, human Th1-like TEM also express 
intermediate level of GATA3 mRNA, in contrast to undetectable T-bet mRNA in Th2-like TEM, 
which could be the reason that Th1 but not Th2 TEM cultured in opposing conditions produced 
opposing cytokines (129). Overexpression of T-bet in Th2-like TEM enabled them to produce 
IFN-γ upon stimulation (129).   
38 
Expression levels of polarized transcription factors are also linked to cell differentiation 
states, which is also critical for memory plasticity. TCM cells, which are thought to be less 
differentiated than TEM cells, have very low T-bet expression compared with TEM (131).  TCM 
cells represent a group of uncommitted cells that are poised to express various cytokines in 
response to corresponding polarizing conditions. Human TCM cells could be easily polarized to 
produce IFN-γ or IL-4 when cultured in Th1 or Th2 conditions (129). In mouse infection model, 
TCM could be induced to express IFN-γ in the presence of IL-12, but they produced IL-4 
without the presence of IL-12 (131). Therefore, TCM cells seem to be in a neutral position when 
differentiating toward Th1 or Th2 cells. However, when human TCM clones were stimulated in 
non-polarizing conditions, a greater proportion of clones predominantly produced IL-4 compared 
with that of IFN-γ producing clones (129), which corresponds to the case that mouse TCM cells 
were spontaneously diverted to IL-4 producing cells without the presence of IL-12 (131). The 
continuous presence of low level GATA3 could be the reason of the greater inclination of TCM 
cells towards Th2 type.   
Collectively, these studies show functional plasticity of memory CD4+ T cells in response 
to the environmental cues and transcriptional change. Functional plasticity enables memory 
CD4+ T cells to tailor the secondary immune responses according to the nature and intensity of 
infection.  
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Section 1.4.5: Memory T cell maintenance 
Once memory T cells are established, they can survive for quite a long time maintaining 
homeostasis by balancing turnover and cell death.  Extrinsic signals are important for keeping 
memory T cells alive. There are two types of extrinsic signals, T-cell stimulation and cytokine 
signals.  Maintenance of memory CD4+ and CD8+ T cells appears to have distinct requirements 
for continuous T-cell stimulation. It has been shown that memory CD8+ T cells can persist 
indefinitely in the absence of MHC-I expression (133), and TCR stimulation is not required for 
long-term CD8+ T cell maintenance (134, 135). In contrast, memory CD4+ T cells show 
functional defects in MHC-II deficient hosts (136, 137), and TCR signaling is required for the 
maintenance of memory CD4+ T cells (138). Previous work from our lab also shows the 
importance of TCR signaling in memory CD4+ T cell maintenance (139). Conditional ablation of 
SLP-76, a signal transducer downstream of TCR, was shown to impair memory CD4+ T cell 
persistence and homeostatic turnover, which cannot be rescued by excess levels of IL-7, 
suggesting that continuous TCR signaling is a predominant factor in regulating memory CD4+ T 
cell maintenance (139).   
Two members of the common gamma chain cytokine family, IL-7 and IL-15, are critical 
for maintenance and homeostasis of memory T cells. The dependence and relative contribution 
of these two cytokines differ for CD4+ and CD8+ T cells. For memory CD8+ T cells, IL-7 is 
mostly important for cell viability, while IL-15 is critical for inducing basal homeostatic 
proliferation (140). IL-7R-defective CD8+ T cells are able to differentiate into effector and 
memory cells, however, these cells show poor persistence, which could be rescued by 
overexpression of Bcl-2 (141).  Antigen specific CD8+ T cells can be generated in IL-15-
deficient mice, but these cells show defects in homeostatic proliferation and gradually 
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disappeared (142). For antigen specific CD4+  T cells, presence of IL-7 and IL-15 are required for 
homeostatic turnover and long-term survival under normal physiological conditions, while IL-7 
plays dominant roles under lymphopenic conditions (106, 143). Therefore, memory CD4+ and 
CD8+ T cells have differential requirements in T-cell stimulation and cytokine signals for cell 
maintenance. 
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Section 1.5: Tissue resident memory T cells 
Section 1.5.1: Memory T cell heterogeneity and tissue residence 
Upon resolution of pathogen infection, most effector T cells die during the contraction 
phase. Although a small subset of surviving cells can persist and develop into memory T cells, 
these persisting memory T cells are poised for rapid production of effector cytokines. Memory T 
cells are a heterogeneous pool distributed in multiple tissue sites. Based on the expression of the 
lymphoid homing receptors CD62L and CCR7, memory T cells were initially grouped into 
CD62Lhi CCR7+ central memory T cells (TCM), which predominantly circulate through 
secondary lymphoid organs (SLOs), and CD62Llo CCR7+ effector memory T cells (TEM), which 
are primarily localized in non-lymphoid tissues (144-146).    
The original report identifying TCM and TEM also found distinct functions associated 
with each subset. In vitro stimulation experiments show that CD4+ TCM cells can produce high 
levels of IL-2, but low levels of effector cytokines like IFN-γ, IL-4 and IL-5; conversely, CD4+ 
TEM cells produce lower levels of IL-2 but rapidly generate high levels of effector cytokines 
(144). Similar to CD4+ T cells, CD8+ TCM and TEM also have differential capacities in the 
production of IL-2 and effector cytokines IFN-γ, and furthermore, CD8+ TEM cells but not TCM 
can produce perforin (144). However, subsequent studies show that both TCM and TEM cells 
can produce effector cytokines in vivo in response to antigens (147-149), but TCM cells have 
greater proliferative capacity compared with the TEM cells (147, 150).   
Besides TCM and TEM, in recent years, a non-circulating populations of memory T cells 
termed tissue-resident memory T cells (TRM) have been identified. TRM cells reside 
permanently in peripheral tissues and they are lack of circulating properties through blood 
stream, which is the key feature of classical TCM and TEM cells. CD8+ TRM have been found 
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in many peripheral tissues including intestine, skin, brain, lung and female reproductive tract 
(151-155). CD4+ TRM have also been found in many tissues including skin, lung, and female 
reproductive tract (156-158). Despite of the discovery of TRM in these tissues, defining a 
memory population as TRM is tricky, because of the presence of TEM that circulate through 
peripheral tissues and the short-term residence in there. 
In order to better identify TRM cells in peripheral tissues, three properties can be 
investigated: the migratory properties, cell surface phenotype, and localization. The key feature 
of TRM cells is their lack of circulation and migration. Parabiosis, a surgery that joins the blood 
circulation systems of two organisms, is a well-established system to investigate the circulation 
of memory subsets. It has been found that in parabiotic mice, antigen specific cells achieve 
rapidly equilibrium in vascularized tissues like lung and liver, a delayed equilibrium in peritoneal 
cavity, and no equilibrium in brain and intestinal epithelium (159).  Subsequent experiments 
using grafted tissue sections found non-circulating tissue resident memory CD8+ T cells in skin, 
ganglia and instine (151, 152, 160), and using parabiosis found non-circulating memory CD8+ T 
cells in female reproductive tract (155).  
Similarly to TEM, TRM also express high levels of CD44 and low levels of lymphoid 
homing receptors CCR7 and CD62L. In addition, TRM also express other key markers. CD8+ 
TRM can be distinguished by their elevated expression of early activation marker CD69 and 
CD103, the α-chain of the integrin αEβ7 (152).  CD4+ TRM also express CD69 and CD11a, the 
α-chain of the integrin LFA-1, but not CD103 (157). However, CD8+ TRM lacking expression of 
CD103 and/or CD69 have been identified (154, 161), and a proportion of CD4+ T cells 
embedded in the tissue and protected from intravascular staining do not express CD69 (157). 
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This heterogeneity in surface phenotype suggests the heterogeneity in the localization and 
function of TRM.  
The localization of memory T cells affects their circulation and migration pattern, and 
may also reflect a distinct differentiation pathway. Therefore, localization is an important factor 
in TRM development. TRM cells have been found in the epithelial layer many tissues including 
skin, gut, lung, and reproductive tract, and they are also found to be localized in the parenchyma 
of many tissues (162). TRM cells can be distinguished from circulating memory T cells by 
intravascular antibody labelling (154, 157), in which circulating T cells is labelled by in vivo 
injected antibody while TRM cells embedded in the tissue are protected from in vivo antibody 
labelling.  
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Section 1.5.2: TRM retention and maintenance 
The defining feature of TRM is their stable retention in peripheral tissues. In order to 
sustain long-term residence of TRM in peripheral tissues, memory T cells need to modulate 
surface expression of cell adhesion molecules, integrins, and chemokine receptors. CD103, the 
α-chain of αEβ7 integrin, is an important marker for CD8+ TRM. CD103 expression can be 
induced by TGF-β signaling in microenvironment. CD103 binds E-cadherin expressed by 
epithelial cells (163), and in this way can promote the adhesion of T cells to tissue epithelia, 
promoting TRM retention. A retention role for CD103 is suggested by results showing that 
CD103-deficient CD8+ T cells can migrate to brain, intestine epithelium, and skin, but they 
cannot persist long-term in the tissue (153, 164, 165). In addition to regulation of cell-cell 
adhesion, CD103 can also increase CD8+ TRM maintenance by promoting CD8+ T cell survival 
in tissues due to increased expression of prosurvival protein Bcl-2 in CD103+CD8+ T cells (153, 
165). However, dependence on CD103 is not absolute since CD8+ TRM lacking CD103 are also 
identified (161, 166) and CD4+ TRM cells do not express CD103 (167, 168).  
CD69 is another important surface marker for TRM, and it also regulates TRM retention. 
During T cell activation, CD69 on T cells sequesters surface S1P receptor, S1PR1, via direct 
binding so that it inhibits T cell response to S1P gradient, and prevents the T cell egress out of 
lymphoid tissues (169). Similarly, preventing the responses to S1P gradient by regulating CD69 
and S1PR1 expression might be a critical mechanism in TRM development. CD69-deficient 
CD8+ T cells cannot persist in the lung and skin epidermis (165, 170), however in other studies 
CD69 deficient T cells can still form TRM (171). S1PR1 downregulation is shown in the core 
transcriptional signature of TRM cells (165), and forced expression of S1PR1 impairs the 
establishment of TRM (172). The transcription factor Kruppel-like factor 2 (KLF2) is required 
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for S1PR1 expression, and downregulation of KLF2 is required for CD8+ TRM formation in 
mice (172). 
Other integrins may also contribute to the TRM retention. CD4+ TRM do not have 
significant expression of CD103, but they have elevated expression of CD11a, the α-chain of 
integrin LFA-1, in the lung after influenza infection, which may contribute to the long-term 
retention of CD4+ TRM (157) (173). VLA-1 (α1β1) integrin, which binds to the extracellular 
collagens and might help T cell retention in tissues, is also expressed on CD8+ TRM in lung and 
skin (165, 174).  
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Section 1.5.3: Transcriptional control of TRM 
As previous stated, relative expression of different transcription factors regulate the 
effector vs. memory differentiation potential during memory T cell generation. Higher 
expression of transcription factors like EOMES, Bcl-6, ID3, TCF-1, and STAT3 favors the 
differentiation toward memory CD8+ T cells, while higher expression of T-bet, Blimp-1, ID2, 
and STAT4 favors the terminal differentiation towards effector CD8+ T cells (112). EOMES and 
TCF-1 are significantly downregulated in the CD8+ TRM in the brain compared with circulating 
memory T cells (175), and EOMES is also significantly downregulated in the CD8+ TRM in the 
skin compared with circulating memory T cells, TCM and TEM (165). In addition, a reduction in 
T-bet expression favors the CD103+CD8+ TRM development (176). Collectively, these data
suggest that CD8+ TRM is in an intermediate differentiated state between terminally 
differentiated effectors cells and less differentiated circulating memory T cells. The data by 
Mackay LK et al. supported this model (177), and show that in mature CD103+CD8+ TRM, 
EOMES expression is reduced while residual T-bet expression is maintained in an intermediate 
level (177). TGF-β has been shown to negatively regulate T-bet expression (176). Forced 
expression of EOMES or T-bet significantly reduces the number of CD8+ TRM, which is 
probably due to the downregulation of TGF-βR by the overexpression of T-box transcription 
factors (177).  
Studies have shown that CD8+ TRM are derived from precursor cells that lack KLRG1 
(165, 178), and single or double copies of T-bet deletion result in the increased proportion of 
KLRG1- TRM precursors and higher level of early CD103+CD8+ TRM infiltration (177). 
However, T-bet deficient cells cannot maintain long-term persistence in tissues due to impaired 
IL-15 signaling and lower CD122 (IL-15Rβ) and Bcl-2 expression, which can be maintained by 
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single copy of T-bet (165, 177). Transcription factors regulating the CD4+ TRM development are 
not well understood. Whether the transcriptional regulation programs in CD8+ TRM also work 
for CD4+ TRM still needs to be investigated.  
48 
Section 1.6: Respiratory infection and lung immunity 
Section 1.6.1: T-cell mediated immune response 
Influenza infection of respiratory epithelial cells results in the activation and maturation 
of antigen presenting cells, especially DCs. Virus antigens are ingested by DCs and carried to 
mediastinal lymph nodes (medLN) as part of the innate immune response and the initiation of the 
adaptive immune response. Naïve T cells expressing lymphoid homing receptors CCR7 and 
CD62L travel through the medLN where they encounter the DCs presenting viral antigens that 
are specifically recognized by corresponding TCR. Activated T cells begin the differentiation 
process to become effector cells that will secret effector cytokines and exert cytolytic functions. 
Priming, clonal expansion and differentiation of influenza-specific T cells in the medLN occurs 
in the D3 to D4 post-infection (179, 180), while viral titers peak at D3 to D5 (181). At days 5-7 
postinfection, there is extensive accumulation of antigen-specific CD4+ and CD8+ T cells in the 
lung (179, 180). The peak of antigen-specific CD4+ and CD8+ effector T cells accumulation in 
the lung is around D10 postinfection accompanied by viral clearance between D7 to D10 (181). 
CD8+ and CD4+ T cells are both important in mediating influenza specific immune responses 
and they display different functional properties in virus clearance. 
Effector CD8+ T cells recognize and kill infected cells in two ways: 1) binding of the 
FAS ligand on CTLs with the death receptor FAS which activates caspase-8, leading to the 
downstream activation of apoptosis pathways; 2) release of cytotoxic granules containing 
perforin, granzymes and granulysin, together of which would ultimately induce apoptosis in 
target cells. Effector cytokines secreted by CD8+ T cells including, IFN-γ and TNF-α, promote 
inflammatory and anti-viral responses. Transfer of antigen-specific CD8+ effector cells can 
protect the transgenic mice from low dose vial challenge (182). In the absence of B cells and 
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antibodies, CD8+ T cells are major force in protecting the hosts (183, 184). However, mice 
deficient in CD8+ T cells can still clear the virus although in a delayed manner (185, 186).  
CD4+ T cells are critical immune response mediators in providing help to CD8+ T cells 
and B cells. Depletion of CD4+ T cells in mice result in significantly reduced recruitment of 
antigen-specific CD8+ T cells to the lung, delayed viral clearance and increased morbidity  (187). 
B cell-deficient mice that are also CD4+ T cell depleted show delayed resolution of influenza 
infection and high mortality, indicating the importance of CD4+ T cell help to CD8+ T cells in 
controlling the infection (188). However, depleting both B cells and CD8+ T cells reduced the 
capacity of these mice in clearing the virus and containing the infection (189, 190).  Effector 
CD4+ T cells in medLN and lung have different functional capacities. Influenza-specific CD4+ T 
cells undergo extensive proliferation in medLN and produce predominantly IL-2; while 
influenza-specific CD4+ T cells in lung show more differentiated phenotype and also undergo 
extensive proliferation, and they produce higher levels of IFN-γ and lower level of IL-2 
compared with cells in the medLN (180). In addition to IFN-γ, CD4+ T cells in lung can also 
perform cytolytic functions using granzyme B and perforin to confer better protection, indicating 
multifunctional properties of these cells (191).  
CD4+ and CD8+ T cells can recognize highly conserved epitopes of influenza virus and 
thus can generate heterosubtypic responses, providing long-term protection. Virus-specific CD8+ 
memory T cells can generate robust cytolytic responses during secondary influenza infection to 
protect hosts from influenza virus insults. Memory CD4+ T cells mediated secondary immune 
protection depends on IFN-γ but is independent of CD8+ T cells and B cells (192). Memory 
CD4+ T cells can also enhance the production of innate inflammatory cytokines and chemokines, 
which are important for early viral control (193).  
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Section 1.6.2: TRM in influenza infection 
Early studies showed that virus-specific CD4+ T cells persisted in lung after respiratory 
infection. These lung retentive memory CD4+ T cells showed activated phenotypes and had 
immediate effector function, and when transferred intratracheally to the host, these cells provided 
substantial secondary immune protection (194). These findings suggested that there is a subset of 
special memory CD4+ T cells in the lung that can generate efficient and robust immune 
responses. Later it was shown that CD4+ TRM in the lung provides optimal protection to 
secondary influenza infection (157). 
The identification of lung TRM was accomplished through transfer studies, parabiosis, in 
vivo antibody labeling and imaging. Adoptive transfer experiment revealed that spleen-derived 
memory CD4+ T cells migrate to multiple tissues, while lung-derived memory CD4+ T cells only 
migrate to the lung, suggesting the tissue-specific tropism of lung-derived memory CD4+ T cells 
(157). Parabiosis experiments further showed that spleen-derived memory CD4+ T cells in the 
hosts can circulate to multiple tissues in the partners, while lung-derived memory CD4+ T cells 
were retained in the lung of the hosts, indicating the retention of lung memory CD4+ T cells and 
the existence of lung-resident memory CD4+ T cells (157). Using in vivo labeling technique after 
influenza infection, the CD4+ TRM were differentiated from circulating TEM in their elevated 
expression of CD69 and CD11a (157), and these CD4+ TRM were found localized in the vicinity 
of lung airways, different from the localization of circulating CD4+ effector cells (167). 
Furthermore, lung-derived memory CD4+ T cells showed better protection to influenza challenge 
compared with exacerbated situation with spleen-derived memory CD4+ T cells (157), which 
corresponds to the finding that CD4+ TRM is the main IFN-γ producer (167). Lung CD4+ TRM 
established after influenza infection were maintained stably independent of lymphocyte egress 
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from lymph nodes (167).  Collectively, these studies provide extensive characterization of lung 
CD4+ TRM with distinct phenotype, function, localization and maintenance.  
Similarly, CD8+ TRM were also identified in lung with elevated expression of CD103 
and CD69 (154, 167). CD4+ T cell help is essential for the CD103+CD8+ TRM establishment 
during influenza infection (176). The generation of CD4+ and CD8+ TRM has been shown to be 
closely related to the site and the route of infection (154, 157, 195). Localized infection in lung 
would promote the generation of lung TRM, while systemic infection could not induce the lung 
TRM establishment. This also holds true for human TRM compartmentalization. Influenza-
specific CD8+ T cells were found predominantly in the lung, while the CD8+ T cells specific for 
systemic virus CMV were found in comparable frequency in the lung and spleen (167). 
Interestingly, influenza-specific CD8+ T cells in the lung had higher expression of CD69 
compared with those in the spleen, which is similar to the influenza-specific TRM in mouse 
model; while CMV-specific CD8+ T cells in the lung and spleen had comparable CD69 
expression (167).  
Virus-specific lung TRM have been shown to provide enhanced protection from virus 
challenge, and optimal protection against heterosubtypic infection (157, 167, 195). These data 
have suggest that vaccines targeting to promote lung TRM development will provide long-term 
protection. Indeed, our lab shows that intranasally-delivered live-attenuated influenza virus 
generated CD4+ and CD8+ TRM that mediated cross-strain protection (196). In the contrast, 
injectable inactivated influenza virus induced strain-specific neutralizing antibodies, and they 
could not provide efficient protection against heterosubtypic infection (196).  
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Section 1.7: Thesis objectives 
Memory CD4+ T cells are a critical component of adaptive immunity providing long-term 
protection. They have lower a response threshold, rapid effector cytokine production and long-
term persistence. Memory CD4+ T cells contain heterogeneous subsets that are comprised of 
central memory (TCM) and effector memory (TEM) T cells that circulate through lymphoid and 
peripheral tissues respectively, and tissue resident memory (TRM) T cells that are retained stably 
in the peripheral tissue. However, molecules that regulate memory CD4+ T cell development and 
tissue targeting remain elusive. Transcription factor T-bet expression level has been shown to 
regulate the potential of effector and memory T cell fate, and it also regulates TRM formation. 
Our central hypothesis is that T-bet is involved in the generation, function, homeostasis 
and tissue targeting of memory CD4+ T cells. 
Multiple studies have shown that T-bet is involved in T cell priming and early 
differentiation, and expression of T-bet is important for effector cytokine production. However, 
the roles of T-bet beyond cell priming and differentiation are not well understood. Therefore, 
our first objective is to determine whether the continuous presence of T-bet is required to 
maintain short and long-term effector functions of CD4+ T cells.  
Many studies investigating the roles of T-bet in the memory T cell development used 
mouse models with early T-bet genomic deletion. However, data generated from these mouse 
models do not clarify whether T-bet is engaged in the memory T cell development after cell 
priming and differentiation. In our second objective, we specifically investigate post-effector 
T-bet expression in regulating memory CD4+ T cell persistence, functional plasticity and
tissue targeting. 
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T-bet genetic deletion is shown to regulate CD8+ TRM formation. It is not clear,
however, whether T-bet expression levels also regulate CD4+ TRM formation. In our third 
objective, we investigate roles of early T-bet genetic deletion in CD4+ TRM formation. This 
serves as a control and complement to our second objective to compare the results of memory 
CD4+ T cell development with different timing of T-bet deletion. 
In total, this body of work promotes understanding of the roles of T-bet in regulating 
memory CD4+ T cell development. Our results showed that T-bet ablated Th1 effector cells 
maintain normal IFN-γ production while producing higher IL-2. T-bet ablated Th1 effector cells 
developed into memory CD4+ T cells with greater functional plasticity, resulting in higher 
expression of IL-17, RORγt, Foxp3 and GATA3. T-bet ablated Th1 effector cells had 
preferential localization in the lung and increased TRM formation when transferred to 
lymphocyte deficient RAG1/2-/- but not immune replete congenic mice. T-bet+/- OT-II cells 
showed increased persistence while T-bet-/- OT-II cells showed decreased persistence after 
influenza infection compared with wild type OT-II cells. However, both T-bet+/- and T-bet-/- OT-
II cells had normal TRM formation. Therefore, our results reveal post-effector T-bet expression 
in regulating effector CD4+ T cell functional maintenance, and memory CD4+ T cell functional 
plasticity, maintenance and tissue targeting. Our results also indicate that the timing control of T-
bet expression and the tissue environment are critical for TRM formation.   
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CHAPTER 2: Materials and Methods 
Section 2.1: Animal breeding and maintenance 
Mice and genotyping 
B6.CD45.1 (B6-Ly5.2) mice were purchased from the Jackson Laboratories. Rag2-/- mice 
were from Taconic Farms and Rag1-/- mice were from Jackson Laboratories. Tbx21F/F and 
Tbx21-/-mice (197) were obtained from Dr. Steven Reiner.  Tbx21F/F mice were crossed to R26R-
EYFP mice (198) to generate Tbx21F/F R26R-EYFP (CKO) and Tbx21F/+ R26R-EYFP (CHET) 
mice. CD4-CreERT2 mice (199) were purchased from Jackson Laboratories and crossed to 
R26R-EYFP and Tbx21F/F R26R-EYFP mice to generate CD4-CreERT2 R26R-EYFP 
(CWTCreT2), CD4-CreERT2 Tbx21F/+ R26R-EYFP (CHETCreT2) and CD4-CreERT2 Tbx21F/F 
R26R-EYFP (CKOCreT2) mice. OT-II mice, which express a transgene that encodes for a T cell 
receptor (TCR) specific for chicken ovalbumin 323-339 presented by MHC class II molecule I-
Ab (200), were maintained within Columbia University Medical Center (CUMC) animal 
facilities. Tbx21-/- mice were crossed to OT-II mice to generate Tbx21-/- OT-II mice. All mice 
were maintained at the animal facilities at the CUMC under specific pathogen-free conditions, 
and animal procedures were conducted according to the NIH guidelines for the care and use of 
laboratory animals and approved by the CUMC Institutional Animal Care and Use Committee 
(IACUC). 
All mouse genotyping was done by PCR reactions using the tail snips of mice and the 
Clontech Terra PCR Direct Polymerase Mix Kit (Takara Bio, Mountain View, CA). Tbx21 
floxed and null alleles were screened by PCR based on the protocol adopted from Dr. Steven 
Reiner’s lab. Primer sets used for Tbx21 allele screening are as follow: 
Primer A: 5'- TAT GAT TAC ACT GCA GCT GTC TTC AG -3'
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Primer B: 5'- CAG GAA TGG GAA CAT TCG CCT GTG -3' 
Primer C2: 5'- CTC TGC CTC CCA TCT CTT AGG AGC -3' 
The wild type allele has the expected band size of 298 bp; the floxed allele has the expected band 
size of 440 bp; the null allele has the expected band size of 400 bp (Figure 2.1). 
The R26R-EYFP alleles were screened using the following primers: 
Primer WT: 5'- GGA GCG GGA GAA ATG GAT ATG -3'  
Primer mutant: 5'- AAG ACC GCG AAG AGT TTG TC -3' 
Primer commom: 5'- AAA GTC GCT CTG AGT TGT TAT -3'   
The wild type allele has the expected band size of 600 bp and the R26R-EYFP allele has the 
expected band size of 320 bp (Figure 2.2). 
The CD4-CreERT2 alleles were screen by PCR as described (199). The following primer 
sets were used: 
Cre-Forward: 5’- TCA AGG CCA GAC TAG GCT GCC TAT -3’ 
Cre-Reverse: 5’- TCT CTG TGG CTG GCA GTT TCT CCA -3’ 
The CD4-CreERT2 allele has the expected band size of 300 bp (Figure 2.2). 
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Figure 2.1: Genotyping PCR for Tbx21 alleles 




Figure 2.2: Genotyping PCR for R26R-EYFP and CD4-CreERT2 alleles 
(Left) Gel image indicating the band positions of PCR products for R26R-EYFP and wild 
type alleles. (Right) Gel image indicating the band positions of PCR products for CD4-CreERT2 
and wild type alleles. 
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Section 2.2: In vivo labeling 
For in vivo antibody labeling, mice were administered I.V. with 2 μg of Alexa-Fluor-700-
conjugated anti-CD4 (clone RM4-5). After 10 minutes, mice were sacrificed and lungs were 
perfused with PBS for subsequent cell isolation. Harvested cells were stained in vitro with anti-
CD4 (clone RM4-4). 
Section 2.3: Lymphocyte isolation 
For lymphocyte isolation from spleens, mediastinal lymph nodes (medLN), or mesenteric 
lymphonodes (mLN), tissues were first disrupted and dissociated by pressing through a 70-um 
cell strainer with the plunger of a syringe to generate single cell suspensions in complete HBSS 
(HBSS containing 5% Fetal Bovine Serum (FBS, Thermo Fisher Scientific), 10 u/mL penicillin 
(Thermo Fisher Scientific) and 10 ug/ml streptomycin sulfate (Thermo Fisher Scientific)). Red 
blood cells in single cell suspensions were lysed by incubation with ACK Lysing Buffer 
(Corning Cellgro, Manassas, VA) for 5 min at room temperature. Cells were then washed, 
resuspended, and filtered through a 40-um cell strainer before subsequent experiment. 
Lung tissues were cut into small pieces and then incubated for 30 min at 37°C with CDTI 
digestion medium (HBSS (Thermo Fisher Scientific) containing 0.1 mg/mL DNase I (Roche, 
Indianapolis, IN), 1 mg/mL collagenase D (Roche) and 1 mg/mL trypsin inhibitor (Invitrogen, 
Carlsbad, CA)). Lung tissue homogenates were then further disrupted and dissociated by 
pressing through a 70-um cell strainer with the plunger of a syringe. Red blood cells from the 
resultant cell suspensions were depleted by incubation with ACK Lysing Buffer for 5 min at 
room temperature. Cells were then washed, resuspended, and filtered through a 40-um cell 
strainer before subsequent experiment.   
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Section 2.4: Flow cytometry and cell sorting 
For analysis of cell surface marker, single-cell suspensions were stained with 
fluorchrome-conjugated antibodies in flow cytometry staining buffer (1% FBS, 0.1% sodium 
azide in PBS) for 30 minutes at 4°C. For intracellular cytokine staining, cells were either 
stimulated with plate-bound anti-CD3 (5 μg/ml) (BD Biosciences, San Jose, CA) and anti-CD28 
(1 μg/ml) (BD Biosciences) for 5 hr or with 50 ng/ml PMA (Sigma-Aldrich) and 1 μg/ml 
ionomycin (Sigma-Aldrich) for 5 hr, and 1 μl/ml Golgiplug (BD Biosciences) was added at the 
beginning of stimulation. Surfaced stained cells were fixed and permeabilized with BD Fix/Perm 
Kit, and stained with anti-IFN-γ, anti-IL-2, anti-IL-17A, and anti-IL-17F antibodies. For 
intracellular transcription factor staining, surface stained cells were fixed and permeabilized by 
eBioscience Foxp3/Transcription Factor Fixation/Permeabilization kit, and then stained with 
anti-T-bet, anti-RORγt, anti-GATA3, and rabbit anti-YFP (Life Technologies), followed by the 
staining of fluorochrome-conjugated anti-rabbit (Cell Signaling) antibody. All sample data were 
collected and ananlyzed using LSRII or Fortessa flow cytometer (BD Biosciences) with 
FACSDiva (BD Biosciences). Flow cytometry data were analyzed with FlowJo software (Tree 
Star, Ashland, OR). For cell sorting, T cells were isolated and stained as mentioned above with 
FACS sorting buffer (2% FBS in PBS), and then sorted by a BD-influx cell sorter (BD 
Biosciences). A complete list of antibodies used, including clone, color and manufacturer, can be 
found in Table 2.1.  
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Table 2.1: Fluorophore-conjugated antibodies used for flow cytometry 
Antibodies used for flow cytometry analysis separated by cell surface stains and 




Target Clone Fluorochrome Manufacturer 
CD3 17A2 BV650 Biolegend 
CD4 RM4-4 Pacific Blue Biolegend 
CD4 RM4-5 Alexa Fluor 700 Life Technologies 
CCR4 2G12 PE Biolegend 
CD69 H1.2F3 PE-Cy7 Biolegend 
CD44 IM7 APC-Cy7 Biolegend 
CD62L MEL-14 BV605 Biolegend 
CD25 3C7 Percp-Cy5.5 Biolegend 
Ly6C HK1.4 BV711 Biolegend 
CXCR3 CXCR3-173 APC Biolegend 
CD45.1 A20 BV510 Biolegend 
CD45.2 104 BV785 Biolegend 
CD11a M17/4 Percp-eFluor710 eBioscience 
CD11a M17/4 PE eBioscience 
Intracellular Stain 
Target Clone Fluorochrome Manufacturer 
IFN-γ XMG1.2 PE-Cy7 eBioscience 
IL-2 JES6-5H4 APC eBioscience 
IL-17F eBio18F10 Percp-e710 eBioscience 
IL-17A eBio17B7 PE eBioscience 
T-bet eBio4B10 PE eBioscience 
RORγt B2D Percp-e710 eBioscience 
GATA3 TWAJ PE-Cy7 eBioscience 
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Section 2.5: Influenza infections 
Mice were anesthetized by inhalation of isofluorane (5% induction/3% maintenance) 
delivered through the respirator. Once the mice were asleep, 20-30 microliter of PR8 influenza 
virus (A/PR/8/34, H1N1) (100-500 TCID50 for sublethal doses) were administered intranasally 
(i.n.) directly to the nares with a micropipette tip. Mice were monitored daily for weight loss and 
morbidity over 14 days. 
Section 2.6: Generation of influenza-specific memory CD4+ T cells 
Naïve CD4+ T cells were isolated from spleens of OT-II mice using a negative T cell 
enrichment kit (EasySep kit, StemCell), and 2x105 purified cells were transferred by i.v. 
injection into naïve congenic (CD45.1) mice 24 hours prior to infection. The following day, 
recipient mice were infected i.n. with a sublethal dose of PR8-OVA influenza virus. For primary 
response studies, mice were sacrificed around D12-D13 post-infection. For memory studies, 
mice were sacrificed > 4 weeks following infection.  
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Section 2.7: In vitro T cell priming and T-bet ablation 
Section 2.7.1: T-bet in vitro ablation and generation of memory CD4+ T cells 
Naïve CD4+ T cells were isolated from the spleens of wild type R26R-EYFP and 
Tbx21F/F R26R-EYFP mice using negative T cell enrichment kit (EasySep kit, StemCell). 
Cells were then activated in vitro by plate-bound anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) in 
Th1 polarizing medium (Complete Clicks medium with 50 U/ml IL-2 (eBioscience), 10 ng/ml  
IL-12 (eBioscience), 1 μg/ml anti-IL4 (eBioscience)) for 3 days. Primed cells were harvested, 
washed and resuspended at 107 cells/ml with Hyclone ADCF-Mab serum free medium (GE 
Healthcare Life Sciences), cultured with equal volume of 100 μg/ml of TAT-Cre (Children’s 
Hospital of Philadelphia, PA) diluted in Hyclone ADCF-Mab serum free medium for 45 min at 
37°C. After culturing with TAT-Cre, cells were washed and replated in Th1 polarizing medium 
for 24 hr, followed by YFP+ cell sorting and adoptive transfer. For the generation of CWTTAT-Cre 
and CKOTAT-Cre memory cells, equal numbers of CD4+YFP+ cells (1.8x105 – 1x106 cells)were 
sorted from the TAT-Cre treated primed cells, transferred I.V. to RAG1/2-/- hosts or B6 CD45.1 
congenic hosts, and harvested 3 - 4 weeks posttransfer (Figure 2.3). Congenic B6 CD45.1 hosts 
were injected I.P. with anti-CD8 (YTS 169.4, 100 μg/mouse) and anti-NK (PK136, 50 μg/moue) 
antibodies at days -1 and 0 and 3-5 days thereafter as described (139).  
Complete Clicks medium: 500 mL Clicks medium, 5 mL HEPES, 5 mL Pen/Strep/L-glutamine, 
3.5 uL β-Mercaptoethanol, 25 mL FBS 
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Figure 2.3: Generation of T-bet ablated memory cells 
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Section 2.7.2: In vivo Brdu incorporation 
Adoptive transfer mouse recipients were administered I.P. with Brdu (1 mg/mouse) 
diluted in PBS daily for 3 days before cell harvest. Intracellular staining of Brdu was performed 
according to the manufacturer’s protocol (BD Biosciences).  
Section 2.8: In vivo T-bet ablation and influenza infection 
CD4-CreERT2 R26R-EYFP (CWTCreT2), CD4-CreERT2 Tbx21F/+ R26R-EYFP 
(CHETCreT2) mice and CD4-CreERT2 Tbx21F/F R26R-EYFP (CKOCreT2) mice were infected 
intranasally with 400-500 TCID50 PR8 influenza virus (A/PR/8/34, H1N1), and then were 
administered I.P. with 2mg/mouse Tamoxifen (Sigma) dissolved in sunflower seed oil (Sigma) 
daily for 5 days from day 8 post-infection (p.i.) to day 12 p.i.. Cells were harvested 3 – 4 weeks 
p.i. (Figure 2.4).
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Figure 2.4: Protocol of Tamoxifen injection 
69 
Section 2.9: Cell sorting, RNA preparation and RNA-Seq analysis 
Section 2.9.1: Cell preparation and sorting 
Wild type R26R-EYFP and Tbx21F/F R26R-EYFP naïve CD4+ T cells were isolated from 
the spleens, and activated and treated with TAT-Cre as described in T-bet in vitro ablation and 
generation of memory T cells section. After TAT-Cre treatment, cells were kept in culture for 
another 48 hr (Figure 2.5). Throughout the whole process, cells were cultured in the Th1 
polarizing medium. Cultured cells were harvested, washed and stimulated with 50 ng/mL PMA 
and 1 ug/mL ION for 5 hr before antibody staining. The stimulated cells were stained with anti-
CD4 and submitted for cell sorting by gating on CD4+YFP+ cells.   
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Figure 2.5: YFP+ cell isolation for RNA-seq 
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Section 2.9.2: RNA isolation and RNA-seq 
RNA from sorted cells was isolated using the Qiagen RNeasy Mini Kit (Hilden, 
Germany). Samples were prepared in duplicate. RNA quality, integrity and concentration were 
measured using Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). All the 
samples had RNA Integrity Number (RIN) values greater than 8. Library preparation and RNA 
sequencing were performed by the Columbia Genome Center. Library preparation was done by 
using Illumina TruSeq RNA prep kit. Libraries were then sequenced by using Illumina HiSeq 
2500 (San Diego, CA). TopHat (201) was used to map gene reads to a mouse reference genome, 
and Cufflinks (202) was used to assess the relative abundance of genes. Differentially expressed 
genes were analyzed by DESeq or DESeq2 (203). Ingenuity Pathway Analysis (Qiagen) was 
used to analyze the downstream biological functional changes.  
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CHAPTER 3: Post-effector requirement for T-bet expression in determining circulating 
and tissue resident memory CD4+ T cell fate 
Memory CD4+ T cell differentiation requires the engagement of master transcriptional 
regulators early during the priming. However, it is not clear whether the post effector presence of 
master transcriptional regulators is required for the generation and functional maintenance of 
memory CD4+ T cells. In this study, we used mouse models with conditional expression of T-bet 
to ablate T-bet expression in CD4+ T cells after priming and effector differentiation to analyze 
the generation, maintenance and tissue localization of the resultant memory CD4+ T cells. We 
found that T-bet-ablation following cell priming and Th1 polarization of CD4+ T cells in cell 
culture did not impair the ability to produce high levels of IFN-γ, nonetheless, there were 
significant increases in IL-2 production. Memory CD4+ T cells developed from T-bet ablated 
effector cells when delivered into lymphocyte deficient RAG1/2-/- mice or intact congenic mice 
had increased persistence, and they maintained lower but significant levels of IFN-γ and higher 
IL-2 production compared with the wild type cells. IL-17 was also significantly upregulated in 
T-bet-ablated memory CD4+ T cells, corresponding to increased RORγt expression. 
Interestingly, increased localization of T-bet ablated memory CD4+ T cells in the lung resident 
niche was found only in RAG1/2-/- hosts but not in congenic hosts, suggesting influence of the 
tissue inflammatory environment in the establishment of TRM cells. In vivo deletion of T-bet 
after influenza infection recapitulates the results as found with RAG1/2-/-. Our findings 
demonstrate a critical role of T-bet in the post-effector regulation on the pathway to generation 
of circulating and tissue resident memory CD4+ T cells.  
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Section 3.1: Introduction 
Memory T cells are characterized by their enhanced functional properties and longevity, 
enabling them to provide long-lasting protection against previously encountered pathogens. 
Memory T cells contain heterogeneous populations distributed in multiple tissue sites, including 
central memory (TCM) and effector memory (TEM) cells that circulate through lymphoid and 
peripheral tissues respectively, and tissue resident memory (TRM) cells that are retained stably 
in peripheral tissues. Transcription factors have been shown to engage early in the process of 
memory development. In T cell priming stage, transcription factors regulate the differentiation 
pathway and function of primed T cells. For CD8+ T cells, relative expression levels of 
transcription factor pairs, such as EOMES & T-bet, Bcl-6 & Blimp-1, ID3 & ID2, and STAT3 & 
STAT4, during cell priming regulate the potential of becoming terminal effector precursors or 
memory precursors (115). For CD4+ T cells, presence of different transcription factors during 
cell priming governs lineage differentiation and effector functions (1). It remains elusive, 
however, that once the differentiation pathway initiated, whether the continuous presence is 
required for memory T cell generation, persistence, functional maintenance, or tissue targeting. 
Therefore, understanding the post-priming regulation of transcription factors will help us 
understand mechanisms underlying memory T cell development.  
T-bet is important for Th1 cell differentiation. IFN-γ production is dramatically decreased
by T-bet-deficient CD4+ T cells (19), and T-bet is involved in chromatin remodeling of Ifng 
locus (39). T-bet also regulates the T cell migratory program by controlling expression of 
chemokine receptors including CXCR3 and CCR5, and chemokines such as CCL3 and CCL4 
(204, 205). For memory T cell development, quantitative expression of T-bet determines the 
effector and memory potential for both CD8+ and CD4+ T cells (115, 122). It has also been 
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shown that TRM maintenance is associated with the expression of an intermediate level of T-bet 
(177). We previously showed that immediate IFN-γ production during rapid recall of memory 
CD4+ T cells occurs without upregulation of T-bet (206).  These data suggest that T-bet 
expression may be differentially required for memory CD4+ T cell differentiation and functional 
maintenance, but the precise role and timing is not clear. 
Many studies about the roles of transcription factors in memory T cells development have 
transcription factor deletion in naïve T cells. The main drawback of this strategy is that it blurs 
the points whether early deletion of these transcription factors affect the cell priming and 
activation or post-priming stages of these cells when transitioning to memory T cells. In order to 
better understand the roles of T-bet in regulation of memory CD4+ T cell generation, persistence, 
function and tissue targeting post-priming, we used a system for T-bet deletion after CD4+ T cell 
priming by administration of TAT-Cre recombinant protein as previously described (139). We 
found that T-bet-ablation of Th1 effector cells did not reduce levels of IFN-γ production and 
resulted in substantial increases in IL-2 production. When transferred to lymphocyte deficient 
RAG1/2-/- mice or congenic mice, T-bet-ablated memory CD4+ T cells persisted in higher 
numbers in the lung compared to wild type memory CD4+ T cells, and upregulated master 
regulator of transcription such as RORγt. T-bet-ablated memory CD4+ T cells were 
heterogeneous in recall function, producing IFN-γ, higher IL-2 and IL-17. Nonetheless, T-bet-
ablated memory CD4+ T cells showed increased localization in tissue resident niche in the lung 
of RAG1/2-/- hosts but not congenic hosts. T-bet in vivo deletion mediated by tamoxifen-induced 
Cre activities after influenza infection also generated similar results as we found when using T-
bet in vitro deletion and RAG1/2-/- mice as hosts. These results demonstrate roles of post-priming 
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T-bet regulation in the generation and function of circulating and tissue resident memory CD4+ T
cells. 
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Section 3.2: Results  
Section 3.2.1: T-bet ablation in Th1 effector cells 
To study the role of T-bet in memory CD4+ T cell development, we used a mouse model 
for conditional ablation of T-bet. We crossed T-betF/F mice with R26R-EYFP mice to generate a 
T-betF/F R26R-EYFP mice with T-betF/+ R26R-EYFP and T-bet+/+ R26R-EYFP mice as controls.
In the presence of Cre recombinase, the floxed gene segments of T-bet gene and the floxed 
STOP cassette preceding YFP gene are deleted by DNA recombination, resulting in the 
generation of T-betΔ/Δ YFP+ (conditional knockout, CKO), T-betΔ/F YFP+ (conditional 
heterozygous control), or T-bet+/+ YFP+ (conditional wild type, CWT) cells.  
In order to better investigate roles of T-bet in specifically for memory CD4+ T cell 
development and maintenance independent of priming, we used a system of in vitro priming and 
conditional gene ablation following activation as previously described (139). CD4+ T cells from 
wild type R26R-EYFP or T-betF/F R26R-EYFP mice were activated by plate-bound anti-CD3 
and anti-CD28 for 48-72 hrs in Th1-priming conditions. Then these primed cells were 
subsequently treated with Cre recombinase fused with HIV TAT protein (TAT-Cre), allowing 
direct entry of Cre recombinase into cell nucleus. CD4+ T cells were stimulated in Th1 
conditions (IL-12 and anti-IL-4) while in culture for optimal T-bet induction. After TAT-Cre 
treatment, cells were rested for 24 hrs before further manipulation (Figure 3.1A). The efficiency 
of TAT-Cre mediated T-bet ablation was assessed at different time points post TAT-Cre 
treatment by measuring YFP expression and concomitant downregulation of T-bet expression.  
YFP expression was detected within 15 hrs after TAT-Cre treatment and reached maximum 
expression by 24 hrs post TAT-Cre treatment (Figure 3.1B). Conversely, T-bet expression was 
down-regulated within 6 hrs of TAT-Cre treatment in CKO cells, and by 15 hrs, it was reduced 
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to the level of isotype control with this background expression level maintained thereafter. By 
contrast, CWT cells exhibited increased T-bet expression with activation, and CHET cells also 
exhibited increased T-bet expression at an intermediate level between CKO and CWT cells 
(Figure 3.1C-D). These results demonstrate that TAT-Cre induces efficient T-bet ablation in 
CKO Th1 effector cells. These data further indicate that T-bet is expressed in a dose-dependent 
manner and T-bet protein expression requires continuous gene transcription.     
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Figure 3.1: T-bet ablation post-priming using a conditional mouse model 
(A) Schematic for T-bet ablation from in vitro primed CD4+ T cells. Naïve CD4+ T cells 
from WT R26R-EYFP or T-betF/F R26R-EYFP mice were stimulated by plate bound anti-
CD3/CD28 for 48-72 hr and then treated with TAT-Cre to induce T-bet ablation. Cells were 
rested for 24 hr and then were used for in vitro analysis or in vivo transfer for memory 
development. CD4+ T cells are kept in Th1 conditions while in culture. (B) YFP expression at 
indicated time points of Th1 effector cells as in (A). YFP expression was assessed by flow 
cytometry 6-24 hrs after TAT-Cre treatment. Cells were gated on total CD4+ T cells. (C) 
Kinetics of T-bet expression after cell activation and TAT-Cre treatment. Naïve CD4+ T cells 
from WT, T-bet F/+ and T-bet F/F R26R-EYFP mice were treated as stated in (A). T-bet 
expression was determined by flow cytometry. Cells were gated on total CD4+ T cells (0-6 hr) or 
CD4+YFP+ T cells (15-24 hr). (D) T-bet ablation in YFP+ cells. (Left) Flow cytometry analysis 
of YFP versus T-bet expression before and 24 hrs after TAT-Cre treatment. Cells were gated on 
total CD4+ T cells. (Right) Histogram overlay of T-bet expression 24 hrs after TAT-Cre 
treatment. Cells were gated on CD4+YFP+ T cells. (B-C) are based on one experiment. (D) shows 
data representative of three independent experiments for WT vs. T-betF/F and one experiment for 







Section 3.2.2: Cytokine expression change in T-bet-ablated primed CD4+ T cells 
During Th1 cell differentiation, T-bet is involved in the chromatin remodeling of Ifng 
locus (39). It was shown that the hyperacetylation status in Ifng promoter of resting Th1 cells 
were maintained in the presence of T-bet, but it was diminished in T-bet deficient cells (207). 
Therefore, early deletion of T-bet could inhibit the chromatin remodeling of Ifng locus, thus 
inhibiting the opening and accessibility of this gene. Whether the presence of T-bet is required 
for IFN-γ production after chromatin remodeling is not well understood.  
We then asked whether continuous T-bet expression in differentiated Th1 effector cells 
was required to maintain IFN-γ production in the short-term. To address this question, we primed 
CD4+ T cells in Th1 conditions and deleted T-bet expression by TAT-Cre as described in Figure 
1. Cells were rested for two days before reactivation. When stimulated with plate-bound
antibody or PMA/ION, the majority of CWTTAT-Cre CD4+ T cells produced high levels of IFN-γ 
along with lower frequency of IL-2 production, reflecting a differentiated Th1 effector profile. 
CKOTAT-Cre CD4+ T cells also produced high levels of IFN-γ comparable to that of the CWTTAT-
Cre CD4+ T cells. However, there was a dramatic increase in IL-2 production in CKOTAT-Cre 
compared to CWTTAT-Cre CD4+ T cells, resulting in a higher percentage of cells producing both 
IFN-γ and IL-2 (Figure 3.2A-B). These data indicate that continuous presence of T-bet in CD4+ 
T cells after priming is not necessary for maintaining the capacity to produce IFN-γ, but IL-2 
production was dramatically increased. The data also suggest that T-bet is a repressor for IL-2 
production.  
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Figure 3. 2: T-bet represses IL-2 expression and is dispensable for IFN-γ production in 
primed CD4+ T cells 
Naïve CD4+ T cells isolated from spleens of WT and T-bet F/F R26R-EYFP mice were 
activated with plate-bound anti-CD3/CD28 in Th1 conditions for 72 hr, treated with TAT-Cre 
and rested for two days in cell culture. Cells were then stimulated with anti-CD3/CD28 or 
PMA/ION for 5 hr and cytokines were analyzed by intracellular cytokine staining (ICS). (A) 
IFN-γ and IL2 production by WT and T-bet ablated CD4+ T cells. Cells were gated on CD4+ 
YFP+ cells. (B) Average percentage of IFN-γ and IL2 expression from ICS assays. (Data are 
representative of two independent experiments. n = 3 per group, results were expressed as mean
± SEM. Significance were determined by two-way ANOVA with Bonferroni post-tests, * p < 
0.05, **p < 0.01, *** p < 0.001, ****p < 0.0001) 
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Section 3.2.3: Memory CD4+ T cell generation and persistence following T-bet ablation 
We next investigated the capacity of T-bet-ablated primed CD4+ T cells to develop into 
memory CD4+ T cells. We transferred CKOTAT-Cre and CWTTAT-Cre cells into lymphocyte 
deficient RAG1/2-/- or congenic B6 CD45.1 hosts and recovered persisting CD4+ T cells at 3-4 
weeks post-transfer as shown in Figure 1A. In RAG1/2-/- hosts, CKOTAT-Cre CD4+ T cells 
persisted in higher frequencies and cell number in the lung compared to CWTTAT-Cre CD4+ T 
cells (Figure 3.3), while comparable frequencies and cell numbers were observed in the spleen 
and mesenteric lymph nodes (mLN) (Figure 3.3). These results indicated a biased persistence of 
CKOTAT-Cre CD4+ T cells in the lung compared to lymphoid tissues. Indeed, the numbers of 
CKOTAT-Cre CD4+ T cells recovered from the lung was ~4-fold higher than in the spleen, while 
the cell number of CWTTAT-Cre CD4+ T cells was only slightly increased in the lung compared to 
spleen. These results suggest that there is lung tropism for CKOTAT-Cre CD4+ T cells resulting in 
better localization and higher infiltration in the lung. 
To further explore the compartmentalization of T-bet-ablated memory CD4+ T cells in 
the lung, we used in vivo labeling to delineate the resident and circulating memory cells (157, 
167). Fluorochrome-conjugated anti-CD4 antibodies were injected i.v. to RAG1/2-/- hosts, and 10 
min later, lung were perfused and cells were harvested.  By this assay, cells in circulating and 
accessible to vasculature become labeled by the i.v. administered antibody, while cells embedded 
in the tissue are protected from the in vivo labeling. We found that CKOTAT-Cre CD4+ T cells had 
a higher frequency of cells in the lung tissue resident niche compared with CWTTAT-Cre CD4+ T 
cells (Figure 3.4A). CKOTAT-Cre CD4+ T cells also had significantly greater cell numbers in the 
tissue resident niche compared with CWTTAT-Cre CD4+ T cells, with only slight increase within 
the circulating niche (Figure 3.4A). These data indicate that under lymhopenic conditions, 
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CKOTAT-Cre CD4+ T cells preferentially infiltrate to the lung resident memory niche, while 
CWTTAT-Cre CD4+ T cells have a lower proportion of lung CD4+ TRM. Taken together with the 
overall cell count data, it is shown that CKOTAT-Cre CD4+ T cells have better persistence, 
especially in the lung, and when recruited to the lung, they are preferentially localized in the lung 
resident memory niche. It could be the cell intrinsic properties that endow CKOTAT-Cre CD4+ T 
cells with preferentially proliferation and localization in the lung. Or it could also be the cell 
extrinsic properties due to the special lymphpenic environment in RAG1/2-/- mice that recruit 
more CKOTAT-Cre CD4+ T cells to the lung and have them proliferate better there.  
In addition to the change in T cell localization, T-bet-ablated memory CD4+ T cells also 
display differences in cell surface phenotype. Ly6C expression level has been shown to be 
regulated by T-bet (122, 208), and accordingly we found that CKOTAT-Cre memory T cells in the 
lung, spleen and mLN had a significant reduction in the Ly6Chi population compared to 
CWTTAT-Cre memory T cells (Figure 3.4B). In addition, CXCR3 is a typical chemokine receptor 
expressed on Th1 cells. Its expression level is also regulated by T-bet. In the spleen and mLN, 
CXCR3 expression was dramatically reduced in CKOTAT-Cre memory T cells, while CXCR3 
expression was also down-regulated in the lung in CKOTAT-Cre memory T cells, but a significant 
level of CXCR3 was maintained (Figure 3.4C). These results provide evidence for maintenance 
of T-bet ablated memory T cells and that continuous T-bet expression is required for target 
molecule expression but not for cell persistence. Moreover, T-bet ablated memory T cells 
exhibited greater persistence and targeting to the tissue resident niche in the lung.  
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Figure 3.3: Adoptive transfer and memory development of T-bet ablated activated CD4+ T 
cells 
Naïve CD4 T cells isolated from spleens of WT and T-betF/F R26R-EYFP mice were 
activated, treated with TAT-Cre, and rested for 24 hr as described before. CD4+YFP+ T cells 
were then sorted and equal numbers of CWTTAT-Cre and CKOTAT-Cre YFP+ cells were transferred 
to lymphocyte deficient RAG1/2-/- mice. Cells were harvested 4 weeks after transfer. (A) 
Frequency of CD4+YFP+ T cells in lung, spleen, and mesenteric lymph node (mLN). Left: Flow 
cytometry analysis of percentage of CD4+YFP+ cells. Right: Individual percentage of harvested 
CD4+YFP+ T cells. (n=3-4 per group. flow cytometry plots were representative of 2 independent 
experiments; scattered plot were pooled data from 2 experiments. Significance were determined 
by two-way ANOVA with Bonferroni post-tests, *p < 0.05, ns p > 0.05). (B) Absolute cell 
counts of CD4+YFP+ T cells in lung, spleen and mLN. Left: Absolute numbers of CD4+YFP+ T 
cells in lung and spleen. Right: Absolute numbers of CD4+YFP+ T cells in mLN. (Data were 
pooled from 2 experiments. Significance were determined by two-way ANOVA with Bonferroni 
post-tests. ****p < 0.0001)  
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Figure 3.4: Localization and cell surface phenotype of T-bet ablated memory CD4+ T cells 
Memory cells were harvested 4 weeks after transfer to the lymphocyte deficient hosts. 
(A) In vivo labeling and differential localization of transferred cells in lung. Hosts that received
WT or T-bet ablated activated CKOTAT-Cre and CWTTAT-Cre CD4+YFP+ T cells were administered 
Alexa 700-congegated anti-CD4 antibody intravenously. Lungs were perfused and cells were 
harvested 10 min later. Left: Representative flow cytometry plots showing percentage of 
CD4+YFP+ T cells labeled (right) or protected (left) from i.v. antibody labeling. Right: Absolute 
cell numbers of circulating and resident CD4+YFP+ T cells ± SEM. (n = 4 per group. Data are 
representative two independent experiments. Significance were determined by two-way ANOVA 
with Bonferroni post-tests. ****p < 0.0001, ns p > 0.05). (B) Ly6C expression by CKOTAT-Cre 
and CWTTAT-Cre CD4+YFP+ T cells in lung, spleen and mLN of RAG1/2-/- hosts. Left: 
Representative flow cytometry plots displaying percentage of cells with CD44hiLy6Chi 
phenotype. Right:  Average percentage of lung, spleen, and mLN CD44hiLy6Chi cells ± SEM. (n 
= 3 per group. Data are representative of two independent experiments. Significance were 
determined by two-way ANOVA with Bonferroni post-tests. ****p < 0.0001, ** p < 0.01 ). (C) 
CXCR3 expression by CKOTAT-Cre and CWTTAT-Cre CD4+YFP+ T cells in lung, spleen and mLN 
of RAG1/2-/- hosts. Left: Representative histograms showing CXCR3 expression in different 
tissue gated on CD4+YFP+ T cells. Right: Average MFI of CXCR3 expression. (n = 3 per group. 
Data are representative of two independent experiments. Significance were determined by two-
way ANOVA with Bonferroni post-tests. * p < 0.05, **** p < 0.0001, ns p > 0.05) 
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Section 3.2.4: Cytokine profile and transcriptional change in T-bet-ablated memory CD4+ 
T cells 
We found T-bet expression is dispensable for IFN-γ production in Th1 effector cells in 
short-term culture 2 days after T-bet ablation. Given the long-term persistence of memory CD4+ 
T cells following T-bet ablation, we asked whether memory CD4+ T cells generated following T-
bet ablation exhibited altered functional recall. Restimulated CWTTAT-Cre memory T cells resulted 
in significant IFN-γ and IL-2 production (Figure 3.5A-B), while CKOTAT-Cre memory T cells 
exhibited significantly lower IFN-γ but higher IL-2 secretion (Figure 3.5A-B). Therefore, T-bet 
expression is required to sustain IFN-γ production in the long-term. However, the substantial 
IFN-γ level in CKOTAT-Cre memory T cells indicate that there’s a T-bet independent mechanism 
for IFN-γ production. 
Since post-effector transcriptional changes would increase functional plasticity of CD4+ 
T cells, we also examined the expression of cytokines from other CD4+ T cell effector types. 
Surprisingly, CKOTAT-Cre memory T cells had dramatic increase in IL-17 production compared 
with CWTTAT-Cre memory T cells, especially those derived from the lung and mLN (Figure 3.5C). 
CWTTAT-Cre memory T cells also had substantial level of IL-17 in the lung and mLN. As 
polarizing transcription factors are important for the expression of signature cytokines associated 
with each CD4+ T cell effector type, we also examined expression of master regulator for IL-17 
cytokine. We found that RORγt was significantly increased in CKOTAT-Cre memory T cells, 
which corresponds to the increase of IL-17 production (Figure 3.5D). T-bet expression in 
CKOTAT-Cre memory T cells was in the isotype control level, while CWTTAT-Cre memory T cells 
still kept a slightly higher T-bet expression level above the background (Figure 3.5D). These data 
indicate that memory CD4+ T cells have some functional plasticity, and when localized in 
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polarizing tissue environment, like the mucosal sites in the lung and mLN, they can be 
repolarized to produce cytokines of other lineages. However, compared with the wild type 
memory CD4+ T cells, T-bet ablation endows memory CD4+ T cells with greater functional 
plasticity regulated by the increased expression of transcription factors controlling diverse 
effector T cell fates.  
91 
Figure 3.5: Functional plasticity of T-bet ablated memory CD4+ T cells 
Memory cells were harvested from lung, spleen and mLN of the lymphocyte deficient 
RAG1/2-/- hosts 4 weeks after the adoptive transfer as in Figure 3.3. (A-C) Cytokine expression 
profile of WT and T-bet ablated memory CD4+ T cells. Harvested cells from lung, spleen and 
mLN were stimulated with PMA/ION for 5 hr, and cytokine expression was analyzed by 
intracellular staining. (A) Flow cytometry analysis of percentage of cells producing IFN-γ and 
IL2 gated on CD4+YFP+ T cells. (B) Average percentage of cells producing IFN-γ and IL2. (C) 
Left: Flow cytometry analysis of percentage of cells producing IL-17 gated on CD4+YFP+ T 
cells. Right: Average percentage of cells producing IL-17.  (D) Transcription factor expression 
of WT and T-bet ablated memory T cells in lung, spleen, and mLN. Cells were stained for 
intracellular transcription factors without stimulation. Upper: Histograms and average MFI of 
RORγt expression with WT (blue) and T-bet ablated (red) cells. Lower: Histograms and average 
MFI of T-bet expression with WT (blue), T-bet ablated (red) and isotype control (shaded). 
Histograms were gated on CD4+YFP+ T cells. (Data are representative of two independent 
experiments and are shown as mean ± SEM. n = 3 per group. Significance were determined by 
two-way ANOVA with Bonferroni post-tests. *** p < 0.001, **** p < 0.0001, ns p > 0.05) 
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Section 3.2.5: T-bet-ablated cells have increased homeostatic proliferation 
Better persistence of CKOTAT-Cre memory CD4+ T cells may be due to the increased 
homeostatic proliferation of these cells. To test this, we used in vivo Brdu incorporation to 
measure their proliferative capacity. One week after the adoptive transfer, both CKOTAT-Cre and 
CWTTAT-Cre CD4+ T cells had significant Brdu incorporation (50-80%), indicating extensive cell 
proliferation (Figure 3.6A). However, CKOTAT-Cre CD4+ T cells had a higher percentage of Brdu 
incorporation compared to CWTTAT-Cre CD4+ T cells, suggesting higher proliferation of CKOTAT-
Cre CD4+ T cells (Figure 3.6A). We also assessed Brdu incorporation at 4 weeks post-transfer to 
measure the turnover in persisting memory CD4+ T cells. There was higher Brdu incorporation 
in CKOTAT-Cre compared with the CWTTAT-Cre memory CD4+ T cells, indicating higher 
homeostatic turnover of    CKOTAT-Cre memory CD4+ T cells (Figure 3.6B). At one week and 4 
weeks post-transfer, higher Brdu incorporation was found preferentially in lymphoid tissues 
compared to the lung (Figure 3.6A-B). This may be due to the better accessibility to pro-survival 
cytokines and more cellular space due to lymphopenic conditions in the lymphoid tissues. These 
data suggest that increased homeostatic proliferation of CKOTAT-Cre CD4+ T cells can contribute 
the better persistence of these cells.  
94 
Figure 3.6: Increased homeostatic proliferation of T-bet ablated CD4+ T cells 
(A) Brdu in vivo incorporation in primed WT and T-bet ablated CD4+ T cells harvested
from the lung, spleen, and mLN one week after adoptive transfer to lymphocyte deficient mice.  
Left: Flow cytometry analysis displaying the percentage of Brdu incorporation. Right: Average 
Brdu incorporation ± SEM (n = 3 – 4, Significance were determined by two-way ANOVA with 
Bonferroni post-tests. * p < 0.05, ** p < 0.01, ns p > 0.05)  (B) Brdu in vivo incorporation in 
primed WT and T-bet ablated CD4+ T cells harvested from the lung, spleen, and mLN four 
weeks after adoptive transfer to lymphocyte deficient mice.  Left: Flow cytometry analysis 
displaying the percentage of Brdu incorporation. Right: Average Brdu incorporation ± SEM (n = 
3. Significance were determined by two-way ANOVA with Bonferroni post-tests. * p < 0.05, ns 
p > 0.05) 
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Section 3.2.6: Development of T-bet-ablated memory CD4+ T cells in congenic mice 
We investigated whether the increased persistence, higher lung localization and 
infiltration, and functional diversifications of CKOTAT-Cre CD4+ T cells will be due to their 
persistence within the lymphopenic RAG1/2-/- environment, and/or intrinsic properties of T cells 
as a result of T-bet ablation. To dissect cell intrinsic versus cell extrinsic induced properties of T-
bet ablated memory CD4+ T cells, we transferred CKOTAT-Cre and CWTTAT-Cre CD4+ T cells to 
wild type congenic mice with intact lymphocytic compartments. CKOTAT-Cre and CWTTAT-Cre 
memory CD4+ T cells developed in congenic hosts exhibited similar cell phenotype, cytokine 
profiles, and functional plasticity as observed in the RAG1/2-/- hosts. We found that CKOTAT-Cre 
memory CD4+ T cells had lower expression of surface marker Ly6C and CXCR3 compared with 
CWTTAT-Cre memory CD4+ T cells (Figure 3.7A). CKOTAT-Cre memory CD4+ T cells maintained 
substantial level of IFN-γ production, and IL-2 expression was higher in all tissues observed 
compared with the CWTTAT-Cre memory CD4+ T cells (Figure 3.7B. A dramatic increase in IL-17 
production was also observed in the CKOTAT-Cre CD4+ T cells (Figure 3.7B).  
When we examined the cell number recovered from different tissues, we still found better 
persistence of CKOTAT-Cre memory CD4+ T cells compared with the CWTTAT-Cre memory CD4+ 
T cells as we saw in RAG1/2-/- mice (Figure 3.7C). However, for both CKOTAT-Cre and CWTTAT-
Cre memory CD4+ T cells, there was a higher cell number in the spleen than in the lung, 
indicating the preferential localization in the lymphoid tissues (Figure 3.7C). When we 
investigated the localization of these cells in the lung by in vivo labeling, we found that over 90% 
of both CKOTAT-Cre and CWTTAT-Cre memory CD4+ T cells were in the circulating niche with 
minimal cell frequency in the resident niche (Figure 3.7D), which is in contrast to the 
preferential localization of CKOTAT-Cre memory CD4+ T cells and substantial localization of 
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CWTTAT-Cre CD4+ T cells in the tissue resident niche when transferred to RAG1/2-/- mice.  
Therefore it appears that the intact environment in the congenic mice affects the localization of 
CKOTAT-Cre memory CD4+ T cells in more extent than CWTTAT-Cre CD4+ T cells. These data also 
suggest that both cell intrinsic and extrinsic conditions confer CKOTAT-Cre memory CD4+ T cells 
preferential localization in the lung tissue resident niche.  
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Figure 3.7: Development of T-bet-ablated memory CD4+ T cells in congenic mice 
Memory cells were harvested 3 weeks after transfer to the congenic hosts. (A) Average 
Ly6C and CXCR3 expression in the lung, spleen, and mLN. Cells were gated on 
CD45.2+CD4+YFP+. Results were expressed as mean ± SEM. (B) Cytokine expression profile of 
CKOTAT-Cre and CWTTAT-Cre memory CD4+ T cells. Cells were gated on CD45.2+CD4+YFP+.
(Left) Average percentage of IFN-γ, IL-2 and IFN-γ IL-2 co-producers. (Right) Average 
percentage of cells producing IL-17. Results were expressed as mean ± SEM. (C) Cell number 
recovered from the lung and spleen. Cells were gated on CD45.2+CD4+YFP+. Results were 
expressed as mean ± SEM.  (D) In vivo labeling and cell localization in the lung. Cells were gated 
on CD45.2+CD4+YFP+. (n=4 per group. Data are representative of two independent experiments. 
Significance were determined by two-way ANOVA with with Bonferroni post-tests. ****p < 
0.0001, *** p < 0.001, **p < 0.01, * p < 0.05, ns p > 0.05 ). 
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Section 3.2.7: In vivo T-bet deletion by Tamoxifen inducible Cre 
To test whether our results using the in vitro priming and T-bet ablation can also be 
recapitulated in a more physiological condition, we devised an in vivo CD4+ T cell priming and 
T-bet ablation by combining influenza infection and tamoxifen inducible CD4 specific Cre
activities. We crossed the CD4-CreERT2 mice with R26R-EYFP mice to generate CD4-
CreERT2 R26R-EYFP mice, and these mice were further crossed with T-betF/F R26R-EYFP 
mice to generate CD4-CreERT2 T-betF/+ R26R-EYFP and CD4-CreERT2 T-betF/F R26R-EYFP 
mice. Administration of tamoxifen induces Cre expression specific to CD4+ T cells that leads to 
the generation of T-betΔ/Δ YFP+ (conditional knockout, CKOCreT2), T-bet+/Δ YFP+ (conditional 
heterozygous, CHETCreT2), and T-bet+/+ YFP+ (conditional wild type, CWTCreT2) CD4+ T cells 
(Figure 3.8).  
We tested the specificity and leakiness of Cre activities in CD4-CreERT2 mouse model. 
After tamoxifen i.p. administration, Cre activities in different tissues and cell types were 
measured by YFP expression. We found that YFP was only induced in CD4+ T cells in different 
tissues, but not in CD8+ T cells, B cells, and TCRγδ T cells (Figure 3.9). Therefore, our mouse 
model shows great specificity of Cre activities in CD4+ T cells with minimal leakiness in other 
cell types. 
To explore the roles of T-bet in the memory CD4+ T cell generation, maintenance, 
function and tissue targeting after cell priming using this model, we infected mice with influenza 
virus and injected tamoxifen from D8 to D12 to delete T-bet expression in CD4+ T cells at the 
peak of T cell response. We found greater numbers of CHETCreT2 CD4+YFP+ cells in the lung 
compared with CWTCreT2 CD4+YFP+ cells 3 weeks after influenza infection (Figure 3.10A).  
Using in vivo labeling to delineate the tissue resident and circulating T cells, we found 
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CHETCreT2 CD4+ T cells have greater percentage of TRM compared with the CWTCreT2 (Figure 
3.10B). We also investigated cytokine profile of these cells.  CHETCreT2 CD4+ T cells had 
comparable IFN-γ but higher IL-2 production compared with CWTCreT2 CD4+ T cells (Figure 
3.10C). CHETCreT2 CD4+ T cells also produced substantial amount of IL-17 with highest level in 
the lung, while CWTCreT2 CD4+ T cells had negligible IL-17 expression after stimulation (Figure 
10D). Therefore, these data demonstrate that, under physiological conditions, lower T-bet 
expression increases CD4+ T cell localization and infiltration in the lung resident niche, confers 
functional plasticity to produce different cytokines like IL-17, and increases IL-2 production. 
These data align with our data from our in vitro cell priming and T-bet ablation system, 
validating our findings that continuous T-bet expression during the activated-to-memory T cell 
transition impacts the homing and functionality of the resultant memory CD4+ T cells.  
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Figure 3.8: Mouse model for tamoxifen-induced knockout of T-bet 
T-betF/F R26R-EYFP mice were crossed to CD4-CreERT2 transgenic mice that express
transgene coding a Cre recombinase-estrogen receptor fusion protein under CD4 gene 
promoter/enhancer/silencer. Tamoxifen administration induces CreERT2 activities and resulted 
in DNA recombination in floxed segments. Therefore, YFP is expressed in cells with T-bet 
deletion, generating CKOCreT2, CHETCreT2, and CWTCreT2 cells from CD4-CreERT2 T-betF/F 
R26R-EYFP, CD4-CreERT2 T-betF/+ R26R-EYFP, and CD4-CreERT2 R26R-EYFP mice 
respectively.   
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Figure 3.9: Tamoxifen induced Cre activation 
Mice were injected i.p. with tamoxifen for 5 consecutive days. YFP expression was used 
to measure Cre activities. Histograms show YFP expression in cells harvested from lung, spleen 
and mLN, and cells are gated for surface markers as indicated.  
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Figure 3.10: Tamoxifen induced T-bet ablation during influenza infection 
Mice infected with influenza virus were administered i.p. with tamoxifen from D8 
to D12 to induce Cre activities and T-bet ablation. Cells were harvested 3 weeks after influenza 
infection. (A) Upper: experiment protocol of influenza virus and tamoxifen injection. Lower: 
Cell number harvested from lung and spleen. Cells were gated on CD4+YFP+ cells. (B) Upper: 
Flow plots showing in vivo labeling of CHETCreT2 and CWTCreT2 CD4+ T cells in the lung. Cells 
were gated on CD4+YFP+. Lower: Average percentage of cells protected from in vivo labeling. 
(C) IFN-γ and IL-2 production of CHETCreT2 and CWTCreT2 CD4+ T cells after PMA/ION
stimulation gated on CD4+YFP+ cells. (D) IL-17 production from CHETCreT2 and CWTCreT2 
CD4+ T cells after PMA/ION stimulation gated on CD4+YFP+ cells. (Data are representative of 
one independent experiment and are shown as mean ± SEM. n = 4 per group. Significance were 
determined by two-way ANOVA with Bonferroni post-tests. ns p > 0.05) 
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Section 3.2.8: Transcriptome analysis of CKOTAT-Cre CD4+ T cells versus CWTTAT-Cre CD4+ 
T cells 
To investigate the molecular basis of intrinsic functional alterations in T-bet ablated cells, 
we used transcriptome analysis to compare gene expression in CKOTAT-Cre and CWTTAT-Cre CD4+ 
T cells. Naïve T-betF/F R26R-EYFP and wild type R26R-EYFP CD4+ T cells were activated by 
plate-bound antibody and treated with TAT-Cre for T-bet deletion as described in Figure 1. The 
resultant cells were rested for additional 48 hrs, and then stimulated with PMA/ION to amplify 
gene expression difference between wild type and T-bet-ablated cells. YFP+ cells were sorted out 
for RNA extraction and whole transcriptome profiling by RNAseq was performed.  
A total of 199 genes were significantly differentially expressed (p < 0.01, padj < 0.01, 
log2 fold change ≥1 or ≤ -1) between CKOTAT-Cre and CWTTAT-Cre CD4+ T cells (Table 3.1 and 
3.2). Among these genes, many are involved in the regulation of immune response (Table 3.3). 
Many genes that are involved in the differentiation of other CD4 effector cell types were 
upregulated in CKOTAT-Cre cells including RORc, Foxp3, and GATA3, consistent with increased 
functional plasticity of these cells. The differential expression gene list also confirmed the in 
vitro and in vivo results, with significant up-regulation of Il17, Il2 and Rorc genes, and down-
regulation of Tbx21 and Ly6c genes. 
We further used Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com) to explore 
pathways involved in functional alterations of CKO compared to CWT cells (Figure 3.11). 
Among the categories of biological functions, a substantial differentially expressed genes were 
involved in the cellular movement, cellular growth and proliferation, and cell death and survival 
(Figure 3.11A). When details of biological function were examined, we found up-regulation of 
biological functions in differentiation of T lymphocytes, T cell homeostasis, cell movement and 
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migration of cells, and proliferation of lung cells (Figure 3.11B). We also found down-regulation 
of biological functions involved in apoptosis of leukocytes and morbidity or mortality. These 
downstream biological function change corresponds to our results showing increased persistence, 
preferential lung localization, and increased functional plasticity. Therefore, the potential of 
CKOTAT-Cre CD4+ T cells undergo different routes of memory development is shown in their 
early gene expression change.    
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Table 3.1: Upregulatd genes in T-bet ablated CD4+ T cells 
Genes significantly (p < 0.01, padj < 0.01, log2 fold change ≥1 or ≤ -1) upregulated in 
CKOTAT-Cre CD4+ T cells relative to CWTTAT-Cre CD4+ T cells after PMA/ION stimulation. 
Genes are listed by decreasing log2 fold change. Genes of interest are bolded.  
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gene CWT_1 CWT_2 CKO_1 CKO_2 log2FoldChange gene CWT_1 CWT_2 CKO_1 CKO_2 log2FoldChange
Hamp -0.88754 -0.82438 1.039444 0.672477 4.942487711 Tpbg -0.89872 -0.75802 1.178584 0.478162 1.779369665
Il17f -0.87778 -0.82404 0.624665 1.077153 3.995579334 Arhgdig -0.95813 -0.76867 0.853211 0.873592 1.769859557
Muc13 -0.86396 -0.73856 0.340787 1.261732 3.916044916 Rab31 -0.89718 -0.79729 1.095996 0.59848 1.760910545
Ifngr2 -0.90458 -0.73599 1.203902 0.436666 3.514316435 Casz1 -0.82861 -0.84662 1.148628 0.526596 1.753648583
Enpp2 -0.95544 -0.77148 0.842739 0.884172 3.352285492 Lrrk2 -1.11662 -0.55534 0.989328 0.682632 1.753502246
Pdzk1ip1 -0.97528 -0.74837 0.902251 0.821405 3.06954409 Il31 -0.77954 -0.91083 0.586326 1.104048 1.734028074
Il24 -0.76817 -0.90162 1.153409 0.516379 3.008359241 Tle1 -1.06294 -0.58087 1.123308 0.520505 1.716584814
Sdc4 -0.85203 -0.77606 1.230235 0.397859 2.983285169 Mob3b -0.98659 -0.66828 1.152043 0.502829 1.710239387
Cdcp1 -0.91872 -0.80728 0.777295 0.948712 2.965654986 Thra -1.04634 -0.65519 0.969664 0.731873 1.697215197
Xlr3b -0.68722 -0.93344 0.396102 1.224553 2.960997589 Pim2 -1.1972 -0.42489 0.998895 0.6232 1.688755291
Cpd -0.99436 -0.71002 1.017526 0.686851 2.94644046 P2ry1 -1.10277 -0.55007 0.586201 1.066631 1.688534805
Cxcl2 -0.9732 -0.69678 1.129065 0.540916 2.924014089 Nr1d1 -1.17928 -0.48032 0.80294 0.856662 1.669153242
Sema3b -1.0383 -0.63012 1.092147 0.576276 2.918257653 Rab34 -1.07815 -0.56865 0.542118 1.104686 1.658361968
Bmp1 -0.84278 -0.72167 1.30432 0.260129 2.904207255 Lgr4 -0.94891 -0.7176 0.520207 1.146301 1.656920033
St8sia6 -0.90937 -0.82152 0.85686 0.874034 2.86272397 Batf -1.21198 -0.42899 0.802326 0.83865 1.653883088
Il1r1 -0.78323 -0.88034 1.169285 0.494287 2.789487089 Ptpn13 -0.80333 -0.81222 1.249335 0.366219 1.643508142
Obsl1 -0.84155 -0.87917 0.998948 0.721773 2.751878448 Spsb1 -0.91285 -0.80885 0.984015 0.737685 1.633407594
Mmp13 -0.94432 -0.73876 1.11185 0.571222 2.724864165 Tgfb3 -0.62194 -1.03892 0.552395 1.108465 1.627657589
Rorc -0.84128 -0.8585 1.085026 0.614761 2.6429899 Sema4c -1.04681 -0.64948 0.70044 0.995858 1.60517608
Cgref1 -1.11778 -0.52144 1.079544 0.559682 2.634603593 Kif21b -1.04272 -0.6612 0.961258 0.742658 1.599081004
Car13 -1.01759 -0.67933 0.670598 1.026317 2.578338875 Gata3 -0.86033 -0.73828 1.266738 0.331877 1.591975738
Gm1045 -0.95061 -0.75655 1.036302 0.670857 2.528999937 Gadd45a -0.84273 -0.86573 1.05536 0.653098 1.587881034
Il22 -0.86673 -0.73505 1.262215 0.33956 2.512916029 Aqp3 -0.71839 -0.96353 1.106578 0.575339 1.579199327
Lad1 -1.04277 -0.6615 0.958881 0.745387 2.49901097 Vldlr -0.76003 -0.95525 0.718409 0.996868 1.570293128
Gm5483 -0.88035 -0.7758 1.182829 0.473322 2.481296022 Slco3a1 -0.84037 -0.88747 0.781932 0.945912 1.568527229
Gm13253 -0.73333 -0.96593 1.056322 0.642944 2.476806466 Ppfia4 -0.86461 -0.85981 0.747396 0.977024 1.547619805
Id1 -1.00641 -0.71239 0.824242 0.894567 2.47297716 Kctd12 -0.85028 -0.87993 0.91956 0.810651 1.535790222
Pkib -0.80352 -0.7722 1.296096 0.279627 2.467223037 Gatm -0.8619 -0.79408 1.185367 0.470611 1.528974542
Il2 -1.10421 -0.47859 0.40473 1.178074 2.446808965 Slc31a2 -0.69736 -0.96027 0.498885 1.158744 1.482074583
Tspan6 -0.88095 -0.69889 1.283644 0.296198 2.434713381 Bmpr1a -1.03846 -0.6439 1.05543 0.626936 1.465356212
Hao1 -0.7354 -0.87177 0.352095 1.25508 2.395668996 Lif -1.0836 -0.57821 0.595673 1.06614 1.464869139
Inhba -0.93096 -0.79643 0.804105 0.923277 2.373899884 Unc13b -1.1586 -0.50963 0.777498 0.890736 1.463811759
Prkar1b -0.88047 -0.71317 1.269214 0.324428 2.359836894 Heg1 -1.11516 -0.57029 0.769177 0.916273 1.45227248
Ccr4 -0.90132 -0.79832 1.079943 0.619699 2.358055701 Nfkbid -1.15998 -0.45769 0.54755 1.070118 1.449274884
Timp1 -0.84995 -0.76006 0.355664 1.25435 2.351990849 Ahr -1.1247 -0.50229 1.095646 0.531341 1.447940803
Ebi3 -1.09194 -0.55099 1.099357 0.543581 2.296691478 Rab20 -1.16328 -0.50467 0.811221 0.856736 1.440879125
Tnfrsf25 -0.99885 -0.72211 0.861987 0.858972 2.271126383 Tdrkh -1.04113 -0.67067 0.831948 0.879845 1.440097613
Igf2bp2 -0.83765 -0.86332 1.081095 0.619879 2.264049241 Cth -0.84848 -0.8153 0.491846 1.17194 1.419219737
Col15a1 -0.9227 -0.7805 1.062521 0.640687 2.252826238 Eno2 -0.75315 -0.96979 0.798137 0.9248 1.416876054
Bcam -0.99953 -0.68261 1.086209 0.59593 2.241672339 Phldb1 -1.04747 -0.64484 1.012017 0.680297 1.416672361
42983 -1.05417 -0.65291 0.801583 0.90549 2.18912021 Mfhas1 -0.86717 -0.75276 0.380268 1.239663 1.408232734
Myo6 -0.79847 -0.92548 0.961822 0.762126 2.129031811 Gpr83 -1.10985 -0.52128 0.527301 1.103832 1.403877779
Myo1d -1.03644 -0.64937 1.046788 0.63902 2.128744139 Nkain1 -1.08065 -0.60497 0.99374 0.691877 1.398781039
Foxp3 -1.25421 -0.34568 0.682425 0.917469 2.070615891 Cd74 -0.90909 -0.76604 0.534493 1.140637 1.397427414
Ptgs2 -1.01748 -0.68183 1.017021 0.682286 2.048422309 Zfp516 -0.91382 -0.72173 1.209252 0.426305 1.390543157
Hmgn3 -0.89808 -0.80789 0.646099 1.05987 2.046259952 Mt2 -0.9345 -0.75045 0.574169 1.110788 1.385368817
Ctla4 -0.98787 -0.71129 1.042724 0.656436 2.026106596 Ptprf -1.24853 -0.35653 0.916452 0.688605 1.369161608
Jag2 -0.87809 -0.77554 1.187548 0.466079 1.95404476 Kremen2 -0.91768 -0.69614 1.237625 0.376202 1.346768454
Adarb1 -0.97622 -0.73099 1.019975 0.687237 1.942791423 Stc1 -0.91491 -0.78578 1.073203 0.627481 1.341122693
Pecam1 -0.9071 -0.79252 0.621004 1.078622 1.942635538 Atg9b -1.11597 -0.57289 0.856699 0.832157 1.340427757
Kcnc3 -1.13696 -0.51807 1.013721 0.641316 1.922725743 Rab11fip1 -1.16971 -0.47227 0.9952 0.646776 1.34034644
Dusp10 -0.79555 -0.84265 1.216079 0.422124 1.909776866 Atp10d -0.99166 -0.72867 0.914414 0.805916 1.331555853
Il18 -1.09928 -0.5882 0.948233 0.739239 1.901396347 Egln3 -0.81299 -0.91336 0.777493 0.948856 1.330002567
Wisp1 -1.14694 -0.52367 0.921427 0.749182 1.889672211 Mt1 -0.78614 -0.91884 0.647255 1.057724 1.325627295
Stab1 -1.01234 -0.62659 1.16551 0.473425 1.882364182 Itga7 -0.443 -1.1322 1.162598 0.412603 1.306613646
Dirc2 -0.92784 -0.77686 1.055561 0.649143 1.87531839 Scn1b -1.08693 -0.60978 0.787869 0.908848 1.303001452
Stra6 -0.83332 -0.87073 0.63352 1.070537 1.822323277 Eef2k -1.09511 -0.6013 0.860074 0.836332 1.294988077
Rxra -1.04072 -0.56153 1.199868 0.402378 1.82158638 Cd1d1 -0.92311 -0.80431 0.93068 0.796738 1.283219491
Gm885 -1.01298 -0.65617 0.560457 1.108693 1.805710299 Ntng2 -0.84863 -0.82744 1.146718 0.52935 1.275516041
Gpr183 -0.70201 -0.96982 1.126717 0.545111 1.785691986 Tnip3 -1.0202 -0.68915 0.746681 0.962668 1.272711798
Normalized FPKM Z score Normalized FPKM Z score
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gene CWT_1 CWT_2 CKO_1 CKO_2 log2FoldChange
Armcx4 -0.53716 -1.14061 0.877734 0.800035 1.272034
Rnf11 -0.99933 -0.70708 1.003936 0.70248 1.26809
Stc2 -0.87752 -0.85397 0.894654 0.836834 1.252071
Hrh2 -1.189 -0.42101 1.042655 0.567358 1.238086
Zfp703 -1.15345 -0.47564 0.573371 1.055725 1.218978
AW046200 -1.1021 -0.53141 1.107284 0.526222 1.218947
Tgfbr1 -1.12941 -0.54965 0.919189 0.759874 1.218679
Cd83 -1.15989 -0.49732 0.959323 0.697881 1.190979
Tec -0.63988 -1.06377 0.914006 0.789644 1.188657
Gramd1a -1.19652 -0.43962 0.682815 0.953328 1.174731
Epb4.1l1 -0.96751 -0.65053 1.21628 0.401755 1.169483
Fndc3b -0.84438 -0.79638 1.212016 0.428742 1.152463
Slc29a2 -1.25106 -0.34192 0.639742 0.953239 1.140493
Actn1 -1.01473 -0.61563 0.453047 1.177314 1.14036
Slc35d3 -1.16147 -0.49557 0.95601 0.701029 1.138094
Serpinf1 -0.48327 -1.09409 1.192032 0.385329 1.117004
Ell2 -1.22294 -0.40994 0.856477 0.776405 1.116494
Smox -0.95129 -0.69336 1.18418 0.460465 1.116246
Hvcn1 -0.80773 -0.91336 0.987564 0.733527 1.107156
Tnfrsf4 -1.25941 -0.3483 0.793473 0.814235 1.107037
Sdc3 -1.09231 -0.5827 0.657907 1.017098 1.10605
Fam132a -0.93289 -0.79603 0.837242 0.891675 1.10471
Rftn1 -1.22264 -0.40411 0.909975 0.716783 1.101542
Ninj1 -1.00698 -0.67815 0.612071 1.073063 1.094168
Smpdl3a -0.96 -0.72839 1.091705 0.596684 1.09183
Gm16907 -0.81502 -0.85357 1.162211 0.506382 1.088742
Ralb -0.84299 -0.88845 0.889207 0.842226 1.083639
Smtn -0.78365 -0.80932 1.277175 0.315792 1.069685
Zbtb10 -1.16661 -0.4594 0.582787 1.043228 1.067024
Utf1 -1.19422 -0.45342 0.897657 0.749979 1.066447
Mir17hg -1.16421 -0.49951 0.906375 0.75735 1.064411
Mcf2l -0.62055 -1.07259 0.971273 0.721868 1.06429
Lamc2 -0.73349 -0.9641 1.062794 0.634797 1.05203
B4galnt4 -1.19388 -0.43579 0.983397 0.646271 1.049902
Hipk2 -1.06954 -0.58188 1.103113 0.548308 1.041715
Ankrd55 -0.57356 -1.09241 1.04505 0.62092 1.039681
Hpcal4 -1.11208 -0.56449 0.978226 0.698349 1.035107
Sdcbp2 -0.88443 -0.78858 1.149913 0.523095 1.032882
Man1a -1.06372 -0.60893 1.058616 0.614034 1.017738
St3gal1 -0.95984 -0.67699 1.193112 0.443714 1.008789
Normalized FPKM Z score
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Table 3.2: Downregulated genes in T-bet ablated CD4+ T cells 
Genes significantly (p < 0.01, padj < 0.01, log2 fold change ≥1 or ≤ -1) downregulated in 
CKOTAT-Cre CD4+ T cells relative to CWTTAT-Cre CD4+ T cells after PMA/ION stimulation. 
Genes are listed by decreasing log2 fold change. Genes of interest are bolded.  
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gene CWT_1 CWT_2 CKO_1 CKO_2 log2FoldChange
Col11a2 0.815869 0.881745 -1.08957 -0.60804 -1.006563802
Ttll3 1.013 0.661967 -0.57973 -1.09524 -1.014406266
Spin4 1.205408 0.428892 -0.93457 -0.69973 -1.018003139
Arsb 0.503199 1.162725 -0.77292 -0.893 -1.033718382
Ptpn5 1.006832 0.681466 -0.62424 -1.06406 -1.0351176
Galnt3 0.932289 0.796856 -0.84352 -0.88563 -1.040953279
Nfe2l2 1.174971 0.478294 -0.93625 -0.71701 -1.104457013
Ivd 0.979394 0.736282 -0.97382 -0.74186 -1.121289239
Lax1 1.118341 0.549196 -0.66442 -1.00311 -1.171257288
Nme7 1.074789 0.617632 -0.72128 -0.97114 -1.182400145
Prr11 1.014726 0.701399 -0.80407 -0.91205 -1.182783351
Ipcef1 1.057616 0.645755 -0.76888 -0.93449 -1.189252254
Bend4 1.019795 0.689099 -0.74264 -0.96625 -1.229985159
Dhx40 0.93169 0.797329 -0.83742 -0.8916 -1.237377157
Mx1 1.180056 0.476944 -0.76863 -0.88837 -1.259931759
Hip1 1.052598 0.615169 -0.58601 -1.08175 -1.29685488
Slc7a11 1.159982 0.346635 -1.20015 -0.30647 -1.298360398
Isg15 0.804522 0.909944 -1.02314 -0.69133 -1.322667677
Shisa3 0.882163 0.848815 -0.90523 -0.82575 -1.328014824
Kcnq5 1.057064 0.645528 -0.76047 -0.94212 -1.337872914
Synpo 1.169532 0.475409 -0.98567 -0.65927 -1.407330401
Dars2 1.074356 0.62339 -0.75951 -0.93824 -1.443438708
Ccdc141 1.065424 0.631208 -0.96486 -0.73177 -1.524413599
Ms4a4c 0.950202 0.757335 -1.03504 -0.6725 -1.531742365
Tbx21 0.857627 0.873919 -0.83736 -0.89419 -1.639824721
Nkg7 0.890001 0.831281 -0.72748 -0.9938 -1.676053863
Amica1 1.050103 0.645444 -0.99482 -0.70073 -1.685102308
Mns1 1.064167 0.640611 -0.89729 -0.80749 -1.730956593
Ly6c2 0.635162 1.064674 -0.75421 -0.94562 -1.807372343
Clec2i 0.89041 0.828846 -1.005 -0.71426 -1.844616761
Il1rl1 1.238044 0.382316 -0.87459 -0.74577 -1.906311494
Mpzl2 1.085033 0.606862 -0.95357 -0.73832 -1.911147268
Fgr 1.085837 0.603271 -0.7211 -0.968 -1.926350802
Gfra1 1.111164 0.573786 -0.93346 -0.75149 -2.109569637
Cldnd2 0.883508 0.847162 -0.81994 -0.91073 -2.262700827
Tox 1.291029 0.2875 -0.83779 -0.74074 -2.533263536
P2rx3 1.275778 0.316054 -0.7433 -0.84853 -2.73366299
Crtam 1.259207 0.345648 -0.74266 -0.86219 -2.796260105
Lypd6b 0.848768 0.881969 -0.91009 -0.82065 -3.51684254
Normalized FPKM Z score
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Table 3.3: Selected immune related genes differentially expressed in T-bet-ablated vs. wild 
type effector CD4+ T cells 
Immune related genes selected from Table 3.1 and Table 3.2. 





































Figure 3.11: Downstream biological function changes 
Genes significantly (p < 0.01, padj < 0.01) were analyzed by IPA for downstream 
biological function changes. (A) Percentage of genes in each function categories. (B) Specific 
function changes sorted by Z-score.    
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Section 3.2.9: Discussion 
In this study, we investigated how the expression level of T-bet in the post-priming stage 
regulated memory CD4+ T cell generation, maintenance, function, and tissue-targeting. We 
showed that short-term T-bet ablation after CD4+ T cell priming did not impair IFN-γ production 
and it promoted significantly higher IL-2 production compared with wild type cells. T-bet-
ablated memory CD4+ T cells had better persistence in the lung and preferential localization in 
the lung resident niche. T-bet ablated memory CD4+ T cells produced significant increased levels 
of IL-17 following stimulation, concomitant with significant elevation of RORγt expression. 
Therefore, T-bet ablation after cell priming increased cell functional plasticity and persistence, 
and promoted localization in the lung resident niche. 
Whether the presence of T-bet is required for IFN-γ production in differentiated Th1 cells 
and memory CD4+ T cells derived from Th1 cells is not well understood. To answer this 
question, we used in vitro priming and TAT-Cre treatment to ablate T-bet from primed Th1 cells. 
Our results showed that short-term T-bet ablation from primed Th1 cells maintained IFN-γ 
production at the same level as wild type effector cells. This result is likely due to the 
maintenance of epigenetic changes in the Ifng locus that facilitate accessibility of the Ifng locus 
by transcriptional machinery. It has been shown that T-bet is involved in chromatin remodeling 
of the Ifng locus during Th1 cell differentiation, resulting in epigenetic changes, especially 
histone acetylation (39). Histone acetylation opens the chromatin, increasing the accessibility of 
genes by transcriptional and regulatory proteins (129, 209-211). The hyperacetylation status in 
the Ifng promoter of resting Th1 cells is maintained stably with the presence of T-bet, but is 
diminished in T-bet-deficient cells (39).Therefore, T-bet-mediated hyperacetylation is required 
for IFN-γ production.  Studies have shown that histone acetylation pattern can survive multiple 
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rounds of cell division and be transferred to daughter cells (129). Therefore, our data support the 
model that T-bet mediated epigenetic change in Ifng locus can be propagated to progeny cells, 
resulting in T-bet independent IFN-γ production. Maintenance of chromatin remodeling is also 
shown in GATA3 mediated IL-4 production, as conditional deletion of GATA3 in mature Th2 
cells maintains a substantial frequency of IL-4 producing cells (50).We previously showed that 
NF-κB activity contributed to rapid IFN-γ production by memory CD4+ T cells (206). Therefore, 
without the presence of T-bet, NF-κB can bind to the open Ifng locus and promote Ifng gene 
transcription.  
T-bet-ablated Th1 effector cells and CKO memory CD4+ T cells showed increased IL-2
production, indicating that T-bet is a repressor for IL-2 production. It has been shown that T-bet 
can inhibit IL-2 production by interfering with NF-κB activities (212). Therefore, increased Il-2 
production in T-bet-ablated cells is likely due to increased NF-κB activities. Indeed, our 
transcriptome analysis results showed upregulation of Nfkid (IκBNS), which promotes NF-κB 
mediated IL-2 production (213).  Our intracellular staining results showed that CKO memory 
CD4+ T cells had dramatic increase in IL-17 production upon stimulation and significant 
elevation of RORγt. Our trancriptome analysis also showed that T-bet-ablated Th1 effector cells 
had upregulation of genes expressed by other CD4+ T cell subsets, such as Il17, RORc, Foxp3, 
and Gata3, indicating functional plasticity of T-bet-ablated CD4+ T cells. As T-bet has been 
shown to inhibit the expression of master regulators of other CD4+ T cell subsets during Th1 
differentiation (41), upregulation of these genes is likely due to the absence of T-bet mediated 
repression.  
Our results show that when transferred to immune deficient RAG1/2-/- hosts, both CWT 
and CKO CD4+ T cells had increased localization in the lung compared to the lymphoid tissues 
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and substantial lung TRM formation; however, when transferred to congenic hosts with intact 
immune system, both CWT and CKO CD4+ T cells had preferential localization in lymphoid 
tissues and they couldn’t form lung TRM. Therefore, the lung environment of the hosts affect the 
localization and lung TRM formation. The inflammatory and antigenic signals are important for 
T cell trafficking and recruitment. Immunodeficient RAG1/2-/- mice may have increased 
inflammation and presence of foreign antigens in the lung due to lack of adaptive immunity 
(214), resulting in increased lung localization and TRM formation. However, wild type congenic 
hosts with full immune complement have trivial inflammation and foreign antigens and therefore 
cannot recruit CD4+ T cells to the lung.    
Even though both CWT and CKO CD4+ T cells could migrate to the lung and form lung 
TRM cells, we found that CKO CD4+ T cells have significantly greater localization in the lung 
and more lung TRM cells than CWT CD4+ T cells when transferred to RAG1/2-/- hosts, 
indicating that there are some cell intrinsic properties of CKO CD4+ T cells making them more 
responsive to the inflammatory lung environment of RAG1/2-/- hosts. Similarly, we also found 
that in our influenza infection and T-bet in vivo ablation system, there were more lung TRM cells 
for T-bet ablated cells than the wild type cells, indicating that T-bet ablated cells are also more 
responsive to influenza induced inflammation in the lung. Since our data show that CKO CD4+ T 
cells have increased cell plasticity, we postulate that these cells may also express many different 
chemokine receptors that are usually expressed by other CD4+ T cell lineages that can facilitate 
lung localization. Indeed, our RNAseq results show that CKO CD4+ T cells have increased 
expression of chemokine receptor CCR4, which is important for T cell migration to the lung 
(215).  We also showed enhanced IL-17 production by CKO CD4+ T cells, and Th17 cells have 
been shown to exhibit extensive tissue infiltration (216). Therefore, increased localization in the 
121 
tissue resident niche may be related to the tissue infiltrating properties of Th17-like CKO CD4+ 
T cells.  
Our Brdu in vivo incorporation data show that CKO CD4+ T cells in lymphoid tissues 
had significant increase in Brdu incorporation compared with the CWT cells, while there was 
only a slight increase in Brdu incorporation in the lung. Therefore, CKO CD4+ T cells have more 
proliferative capacity in the lymphoid tissues than in the lung.  Taking together the significantly 
higher cell number recovered from the lung than from the lymphoid tissues in the RAG1/2-/- 
hosts, we postulate that lymphoid tissues are the main location of homeostatic proliferation and 
the cells generated in the lymphoid tissues then migrate to the lung in response to inflammatory 
signals, resulting in the preferential localization and greater cell number of CKO CD4+ T cells in 
the lung.  
T-bet expression level is correlated with the differentiation state and the potential of 
becoming effector and memory T cells (115, 122). Therefore, from the perspective of T cell 
differentiation, T-bet ablation affects the differentiation state of CD4+ T cells, which may drive 
TRM establishment. Genetic reduction of T-bet by one half increased the percentage of CD8+ 
TRM cells expressing CD103 (176). A residual expression of T-bet is maintained in mature 
CD103+CD8+ TRM (177).  Therefore, TRM appears to be in an intermediate differentiation 
state, while keeping the residual T-bet can confer them rapid effector reaction during immune 
response. It has been shown that pro-memory transcription factor EOMES is downregulated in 
CD8+ TRM compared with the circulating memory T cells (165, 175).  T-bet dosage reduction 
also increased the proportion of KLRG1- TRM precursors and promoted higher level of early 
infiltration of CD103+CD8+ T cells (177).  However, T-bet-deficient cells could not maintain 
long-term persistence in tissues (177). Collectively, these data indicate that downregulation of T-
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bet drives TRM in an intermediate differentiation state, which is necessary for their migration to 
peripheral tissue and long-term maintenance.  Therefore, in our data, T-bet ablation form primed 
CD4+ T cells drive the cells to a less differentiation state to promote their migration to the tissue 
and maintain long-term persistence. The increased functional plasticity and IL-2 production also 
reflect the less differentiation state of T-bet ablated CD4+ T cells.  
In total, the work present here show that post-priming presence of transcription factor T-
bet is dispensable for the effector cytokine expression, but its absence enhances functional 
plasticity and drives TRM establishment. Our results highlights the post-priming regulation for 
generating circulating and resident memory generation, and provides insight into targeting T-bet 
as potential regulator for TRM formation.   
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CHAPTER 4: Roles of T-bet in CD4+ TRM development after influenza infection 
T-bet is critical for Th1 cell differentiation and it is important for CD8+ TRM formation. 
However, the roles of T-bet during CD4+ TRM development is not clear. In this study, we used 
transgenic T-bet+/- and T-bet-/- OT-II mice to investigate maintenance and localization of antigen 
specific CD4+ T cells. After PR8-OVA influenza virus infection, we found T-bet+/- OT-II cells 
had better persistence both in the early phase and memory development phase of infection 
compared with the wild type (WT) OT-II cells. However, T-bet-/- OT-II cells had decreased 
persistence both in the early phase and memory development phase of infection compared with 
WT OT-II cells. T-bet+/- and T-bet-/- OT-II cells had normal TRM development. Ly6C and 
CXCR3 expression were reduced with T-bet dosage reduction and had almost diminished levels 
in T-bet-/- OT-II cells. Therefore, our results show that T-bet genetic dosage regulates the 
persistence and maintenance of CD4+ T cells with no effect in the TRM formation.    
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Section 4.1: Introduction 
CD4+ T cells are critical for the antiviral immune responses. Effector CD4+ T cells can 
produce IFN-γ to contain influenza infection (180). In addition, CD4+ T cells also express 
cytolytic molecules to provide better protection (191). Memory CD4+ T cells recognize highly 
conserved epitopes of influenza virus and thus can provide heterosubtypic protection to the host. 
During secondary infection, memory CD4+ T cells mediate rapid lung viral clearance and protect 
lethal infection, which is dependent on IFN-γ but not CD8+ T cells and B cells (192). It was later 
shown that CD4+ TRM in the lung is the major force providing immune protection against 
influenza infection (157). However, the molecules that are involved in the CD4+ TRM 
development are not clear. 
Lung-derived memory CD4+ T cells had preferential migration and localization to the 
lung, indicating a tissue-specific tropism, and these cells provided better protection against 
influenza challenge compared to spleen-derived memory CD4+ T cells (157). In vivo labeling 
identified CD4+ TRM cells with elevated expression of CD69 and CD11a, and these cells are the 
major IFN-γ producers, which may contribute to the better protection by lung-derived memory 
CD4+ T cells (157, 167). Since T-bet regulates IFN-γ production in Th1 cells (19) and T-bet is 
also involved in the regulation of cytolytic function of CD4+ T cells during influenza virus 
infection (217), it is tempting to relate T-bet expression with CD4+ TRM function.  
Nonetheless, T-bet expression has also been shown to regulate the establishment of CD8+ 
TRM in different tissues. As discussed in previous sections, a residual level of T-bet is 
maintained in mature CD103+CD8+ TRM (177), and reduction in T-bet allele dosage increased 
percentage of CD8+ TRM and the KLRG1- TRM precursors, and promoted early tissue 
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infiltration (176, 177). Therefore, T-bet expression is important for TRM function and 
establishment.  
In this study, we used transgenic T-bet+/- OT-II and T-bet-/- OT-II mice to investigate the 
roles of T-bet in antigen-specific CD4+ TRM development.  After adoptive transfer and influenza 
infection, T-bet+/- OT-II cells showed increased cell number and percentage, while T-bet-/- OT-II 
cells had lower cell number and percentage compared with the wild type OT-II cells. However, 
both T-bet+/- and T-bet-/- OT-II cells showed comparable TRM percentage compared with the 
wild type cells. T-bet-/- OT-II cells had significant lower expression of IFN-γ. Our results show 
that T-bet is critical for memory CD4+ T cell maintenance and effector, but is dispensable for 
infiltration to lung resident niche.  
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Section 4.2: Results 
Section 4.2.1: T-bet expression in CD4+ T cells from different lung compartments 
CD4+ TRM cells can provide optimal protection to the hosts. As Th1 cells mediate anti-
viral immune response, we investigated whether Th1 master regulator T-bet was expressed in the 
effector CD4+ T cells in the lung. We used in vivo antibody labeling to delineate the resident and 
circulating cells. Fluorochrome-conjugated anti-CD4 antibody was injected i.v. to influenza 
infected C57BL/6 (B6) mice, and 10 min later, lungs were perfused and cells were harvested. 
Cells that are accessible to the vasculature are labeled with i.v. administered antibody (labeled 
cells), while cells embedded in the tissue are protected from i.v. antibody labeling (protected 
cells). We found that at 10 days post-infection (p.i.), over 60% of protected CD4+ T cells 
expressed T-bet, while there was only ~20% of labeled CD4+ T cells expressed T-bet (Figure 
4.1). As T-bet mediate IFN-γ production, we investigated IFN-γ production by protected and 
labeled CD4+ T cells. We found significant higher IFN-γ production from protected CD4+ T cells 
compared with labeled cells, corresponding to the higher T-bet expression in protected cells 
(Figure 1). Therefore, our data indicate that T-bet mediates T cell immune response during 
influenza infection, especially for CD4+ T cells embedded in the lung tissue.       
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Figure 4.1: T-bet and IFN-γ expression in CD4+ T cells from different lung compartments 
Wild type B6 mice were infected with PR8 influenza virus. At 10 days p.i. mice were 
administered Alexa 700-conjugated anti-CD4 antibody intravenously, and lungs were perfused 
and cells were harvested 10 min later. Cells in circulating were labeled by the i.v. administered 
antibody (labeled cells, red borders), while cells embedded in the tissue were protected from the 
i.v. administered antibody labeling (protected cells, blue borders). Top: Flow cytometry plots
showing protected and labeled cells. Middle: T-bet expression by protected and labeled cells. 
Bottom: IFN-γ expression by protected and labeled cells. Lung cells were simulated by 
PMA/ION and IFN-γ was stained through intracellular staining.  
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Section 4.2.2: T-bet expression and antigen-specific CD4+ T cell development 
We next investigated how T-bet expression affect the memory development and memory 
cell tissue targeting during influenza infection. We crossed T-bet-/- mice to TCR transgenic OT-II 
mice expressing TCR specific for a chicken ovalbumin (OVA) peptide (323-339) presented by 
the MHC class II molecule to generate T-bet+/- OT-II and T-bet-/- OT-II mice.  
We first compared differential memory T cell development between T-bet+/- OT-II and 
wild type (WT) OT-II cells. Equal numbers of T-bet+/- OT-II and WT OT-II cells were 
transferred to congenic hosts respectively, followed by influenza infection by PR8-OVA virus, 
which expresses OVA peptide (323-339) that are specifically recognized by OT-II cells. At 12 
days p.i., we found T-bet+/- OT-II cells had greater frequency and cell number in the lung, spleen 
and medLN compared with WT OT-II cells, with highest frequency and cell number in the lung 
(Figure 4.2A-B). Using the in vivo labeling to differentiate cells in circulating and embedded in 
the tissue, we found most of the WT OT-II cells were embedded in the tissue, indicating 
extensive effector cells infiltration at the early phase of influenza infection. T-bet+/- OT-II cells, 
however, had comparable in vivo labeling protected cells as the WT OT-II cells (Figure 4.2C).  
When comparing the T-bet expression level in the lung, we found that WT OT-II protected cells 
had high T-bet expression, and WT OT-II labeled cells were heterogeneous in T-bet expression; 
while both T-bet+/- OT-II protected and labeled OT-II cells had low T-bet expression (Figure 
4.2D). Therefore, it corresponds to the endogenous T-bet expression data in Figure 4.1, 
indicating that protected cells are the major effector cells.  
We also assessed the surface phenotype change between T-bet+/- OT-II and WT OT-II 
cells. Ly6C expression was decreased in the lung, spleen and medLN of T-bet+/- OT-II cells 
(Figure 4.2 E). Chemokine receptor CXCR3 had slight decreased expression in the spleen and 
130 
medLN of T-bet+/- OT-II, while it had comparable expression as WT OT-II cells in the lung, 
indicating that single copy of T-bet allele is sufficient to maintain CXCR3 expression (Figure 4.2 
F).  At four weeks post-infection, we still found T-bet+/- OT-II memory cells had better 
persistence than WT OT-II memory cells (Figure 4.3A-B). Nonetheless, the percentage of OT-II 
TRM cells were similar between T-bet+/- OT-II and T-bet+/- OT-II memory cells (Figure 4.3C). 
Therefore, our data indicate that T-bet+/- OT-II cells have increased persistence in terms 
of overall T cell numbers in both early phase and memory phase of the influenza infection. The 
overall increased persistence of T-bet+/- OT-II cells may also result in increased lung TRM cell 
numbers, but this does not necessarily mean that  T-bet+/- OT-II cells have enhanced capacity to 
form TRM cells. When assessing the capacity to form lung TRM cells by the percentage of cells 
protected from in vivo labeling, our data show that genomic reduction of T-bet by one half does 
not impair their capacity to become TRM cells.  
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Figure 4.2: Antigen specific immune response of T-bet+/- OT-II cells 
T-bet+/- OT-II and WT OT-II cells were transferred to congenic hosts and infected by
PR8-OVA virus. At 12 days p.i., congenic hosts were administered anti-CD4 antibody and lungs 
were perfused and cells were harvested from different tissues 10 min later. (A) Flow cytometry 
plots showing the frequencies of T-bet+/- and WT OT-II cells in the lung, spleen and medLN. (B) 
Upper: Average frequency of OT-II cells in the lung, spleen, and medLN. Lower: Average OT-II 
cell number recovered from the lungs and spleens.  (C) Flow cytometry plots showing in vivo 
labeling of OT-II cells gated on CD4+CD45.2+Vβ5+. (D) T-bet expression by in vivo labeling 
protected and labeled T-bet+/- and WT OT-II cells in the lung. Cells were gated on 
CD4+CD45.2+Vβ5+. (E) Ly6C expression by T-bet+/- and WT OT-II cells in different tissues 
gated on CD4+CD45.2+Vβ5+ cells. (F) CXCR3 expression by T-bet+/- and WT OT-II cells in 
different tissues gated on CD4+CD45.2+Vβ5+ cells. (n = 5-8. Data were pooled from two 
independent experiments. Significance were determined by two-way ANOVA with with 
Bonferroni post-tests. ****p < 0.0001, *** p < 0.001, **p < 0.01, * p < 0.05, ns p > 0.05 ). 
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Figure 4.3: T-bet+/- and WT OT-II memory cell persistence and localization in the lung 
Four weeks after OT-II cell transfer and PR8-OVA virus infection, cells were harvested 
for analysis. Congenic hosts were administered anti-CD4 antibody and lungs were perfused and 
cells were harvested from different tissues 10 min later. (A) Flow cytometry plots showing 
percentage of transferred OT-II cells in the lung. (B) Average frequency and cell number of 
transferred OT-II cells in the lung. (C) Flow cytometry plots showing in vivo labeling of T-betand 
WT OT-II cells in the lung. (n = 3-4. Data are representative of one experiment. Significance 
were determined by two-way ANOVA with with Bonferroni post-tests.  **p < 0.01, * p < 0.05). 
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Since retention of one copy of T-bet allele still contribute effector functions of CD4+ cells, we 
further investigated whether using T-bet total deficient cells would exacerbate the antigen specific CD4+ 
T cell development and tissue localization.  Equal numbers of T-bet-/- and WT OT-II cells were 
transferred to congenic hosts respectively, followed by PR8-OVA influenza virus infection. 
When cells were harvested at 13 days p.i., we found decreased cell frequency and numbers of T-
bet-/- OT-II cells compared with WT OT-II (Figure 4.4A-B), which is contradictory to the higher 
cell frequency and numbers of T-bet+/- OT-II cells shown in previous section. However, the 
percentage of OT-II cells embedded in the lung tissue was similar between T-bet-/- and WT OT-
II cells, indicating that T-bet-deficient cells still have the ability of infiltrating lung tissue (Figure 
4.4C).  T-bet-/- OT-II cells had diminished T-bet expression in in vivo protected and labeled cells 
in the lung, while WT OT-II cells embedded in the lung still expressed highest level of T-bet and 
heterogeneous T-bet expression was found in WT OT-II in vivo labeled cells (Figure 4.4D). 
Ly6C and CXCR3 were almost diminished in the T-bet-/- OT-II cells (Figure 4.4 E-F). Compared 
to substantial Ly6C and CXCR3 in T-bet+/- OT-II cells, these data indicates that Ly6C and 
CXCR3 expression is dependent on the dose of T-bet.  
We then investigated the persistence of T-bet-/- OT-II cells. At four weeks post-infection, 
we also found lower cell frequency and numbers of T-bet-/- OT-II cells compared with the WT 
OT-II cells as we found in the early phase of influenza infection (Figure 4.5A-B).  However, T-
bet-/- OT-II cells still had comparable percentage of cells protected from in vivo labeling as WT 
OT-II cells, indicating that T-bet-deficiency does not inhibit their capacity to become TRM cells 
(Figure 4.5C). Ly6C was dramatically reduced and CXCR3 expression was diminished in T-bet-/- 
OT-II memory cells as found before (Figure 4.5 D-E). We also compared the cytokine profile of 
these cells. Upon stimulation, WT OT-II cells produced significant amount of IFN-γ and IL-2. 
While T-bet-/- OT-II could produce comparable IL-2 as WT OT-II, however they had dramatic 
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decrease in the IFN-γ production (Figure 4.5F). Therefore, these data show that unlike T-bet+/- 
OT-II cells, T-bet-/- OT-II cells has decreased cell persistence both in the early and memory 
phase of influenza infection. T-bet deficiency also impairs their ability to produce IFN-γ.     
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Figure 4.4: Antigen specific immune response of T-bet-/- OT-II cells 
T-bet-/- OT-II and WT OT-II cells were transferred to congenic hosts and infected by
PR8-OVA virus. At 13 days p.i., congenic hosts were administered anti-CD4 antibody and lungs 
were perfused and cells were harvested from different tissues 10 min later. (A) Flow cytometry 
plots showing the frequency of T-bet-/- and WT OT-II cells in the lung, spleen and medLN. (B) 
Upper: Average frequency of OT-II cells in the lung, spleen, and medLN. Lower: Average OT-II 
cell number recovered from the lungs and spleens.  Cells were gated on CD4+CD45.2+. (C) Flow 
cytometry plots showing in vivo labeling of OT-II cells gated on CD4+CD45.2+. (D) T-bet 
expression by in vivo labeling protected and labeled T-bet-/- and WT OT-II cells in the lung. 
Cells were gated on CD4+CD45.2+. (E) Ly6C expression by T-bet-/- and WT OT-II cells in 
different tissues gated on CD4+CD45.2+ cells. (F) CXCR3 expression by T-bet+/- and WT OT-II 
cells in different tissues gated on CD4+CD45.2+ cells. (n = 4. Data were representative of one 
independent experiments. Significance were determined by two-way ANOVA with with 
Bonferroni post-tests. * p < 0.05, ns p > 0.05 ). 
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Figure 4.5: Persistence, localization and function of T-bet-/- OT-II memory cells 
Four weeks after OT-II cell transfer and PR8-OVA virus infection, cells were harvested 
for analysis. Congenic hosts were administered anti-CD4 antibody and lungs were perfused and 
cells were harvested from different tissues 10 min later.  (A) Flow cytometry plots showing the 
frequency of T-bet-/- and WT OT-II cells in the lung, spleen and medLN. (B) Upper: Average 
frequency of OT-II cells in the lung, spleen, and medLN. Lower: Average OT-II cell number 
recovered from the lungs and spleens.  Cells were gated on CD4+CD45.2+. (C) Flow cytometry 
plots showing in vivo labeling of OT-II cells gated on CD4+CD45.2+. (D) Ly6C expression by T-
bet-/- and WT OT-II cells in different tissues gated on CD4+CD45.2+ cells. (E) CXCR3 
expression by T-bet+/- and WT OT-II cells in different tissues gated on CD4+CD45.2+ cells. (F) 
Cytokine expression by T-bet-/- and WT OT-II cells. Cells were stimulated with PMA/ION for 5 
hr before inctracelluar staining for cyotkines. (n = 3-4. Data were representative of one 
independent experiments. Significance were determined by two-way ANOVA with with 
Bonferroni post-tests. * p < 0.05, ns p > 0.05 ). 
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Section 4.3: Discussion 
In this study, we used antigen specific CD4+ T cells with genetic reduction of T-bet to 
assess the roles of T-bet in memory development. We found T-bet+/- OT-II cells had increased 
persistence and T-bet-/- OT-II cells had decreased persistence compared with WT OT-II cells 
after influenza infection. Both T-bet+/- and T-bet-/- OT-II cells had similar percentage of tissue 
embedded cells in the lung as WT OT-II cells in both early phase and memory phase of influenza 
infection. Therefore, different T-bet genomic doses regulate the overall maintenance of memory 
CD4+ T cells in different manners and however, T-bet genomic dose change does not affect the 
capacity of lung TRM formation.  
The differential cell persistence of T-bet+/- and T-bet-/- OT-II cells may depend on their 
differential memory potential and clonal expansion capacity. T-bet expression level balances the 
potential of CD8+ and CD4+ T cells to become terminal effector or memory cells, with lower T-
bet expression favors memory precursors and higher T-bet expression promotes terminal effector 
precursors. Therefore, the increased persistence observed in T-bet+/- OT-II cells could be due to 
the preferential memory precursor development. However, total T-bet deficiency have 
detrimental effects. Previous studies have shown that T-bet-/- cells have lower clonal expansion 
(115, 122). Therefore, decreased persistence of T-bet-/- OT-II cells may be due to the impaired 
priming and clonal expansion of these cells. 
Previous studies showed increased early tissue infiltration and enhanced TRM formation 
by T-bet+/- CD8+ T cells, while T-bet-/- CD8+ T cells also showed increased early tissue 
infiltration, but they had impaired long-term persistence (176, 177). Integrin CD103 expression 
was enhanced in both T-bet+/- and T-bet-/- CD8+ T cells, which may account for the increased 
early tissue infiltration (176, 177). However, in our studies, both T-bet+/- and T-bet-/- cells 
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showed normal tissue infiltration and TRM formation in the lung. The discrepancy may be in the 
intrinsic difference between CD4+ and CD8+ T cells. CD103 is mainly expressed by CD8+ T 
cells but not by CD4+ T cells. CD69, another TRM surface marker that regulates the egress of 
lymphocytes by blocking S1PR1 function (169), are expressed by both CD8+ and CD4+ T cells. 
CD4+ T cells tissue retention may rely on CD69, whose expression is not regulated by T-bet 
(data not shown). That could be the reason why we did not see difference in the TRM formation 
of T-bet+/- and T-bet-/- cells. Chemokine receptor CXCR3 is important for cell migration. Our 
data showed that T-bet-/- OT-II cells with diminished CXCR3 expression had normal TRM 
formation, which indicate that CXCR3 is not essential for TRM formation during influenza 
infection. Other chemokine receptors may be involved in the pro-inflammatory migration to 
substitute CXCR3 during TRM formation.  
Overall, our data show that genetic reduction of T-bet in naïve CD4+ T cells regulates the 
persistence and maintenance of memory CD4+ T cells, and it does not interfere with TRM 
formation.  However, in combination with our results from Chapter 3 using post-effector T-bet 
ablation system, collectively they suggest the timing of T-bet regulation is essential for memory 
CD4+ T cell development, especially TRM cells. 
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CHAPTER 5: Conclusion 
Memory T cells are an important component of adaptive immunity. They are 
characterized by lower response threshold, rapid and enhanced effector cytokine production, and 
long-term persistence. Therefore, memory T cells can provide long-lasting protection against 
previously encountered pathogens. Memory T cells contain heterogeneous populations 
distributed in multiple tissue sites, including TCM that circulates through secondary lymphoid 
tissues, TEM that circulates to non-lymphoid tissues, and TRM that are maintained stably in the 
peripheral tissues. TRM cells have been found in many tissues including skin, lung, female 
reproductive tract, and brain (162). However, the molecules that regulate memory CD4+ T cell 
generation, function, homeostasis and tissue targeting are not well understood.  
Transcription factors have been shown to engage early in the process of memory 
development. During T cell priming and differentiation, expression levels of transcription factors 
regulate functions and differentiation pathways of effector T cells. Transcription factor T-bet is 
an important transcription factor for effector T cell function and memory T cell development. T-
bet regulates the Th1 cell differentiation (80) and it is involved in the chromatin remodeling of 
the Ifng locus (39). T-bet expression levels determines effector and memory potential for both 
CD8+ and CD4+ T cells (115, 122). Nonetheless, T-bet expression levels also regulate CD8+ 
TRM formation (176, 177). We previously show that T-bet was not engaged in immediate IFN-γ 
production during rapid recall of memory CD4+ T cells (206). However, the roles of T-bet in 
memory CD4+ T cell development are still not well understood. The work presented in this thesis 
reveals the roles of T-bet in regulating memory CD4+ T cell generation, function, homeostasis 
and tissue targeting.   
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T-bet is engaged in early T cell priming and differentiation. However, whether T-bet
continuous presence is required for functional maintenance and memory CD4+ T cell 
development is not clear. To address this question, we studied the post-effector requirement for 
T-bet expression in memory CD4+ T cell development. Many studies have used mouse models
with T-bet deletion in naïve T cells to assess the roles of T-bet in memory T cell development. 
This approach blurs the points whether T-bet is required for early T cell priming or post-priming 
regulation. We therefore used mouse models with conditional expression of T-bet, in which we 
used in vitro priming and TAT-Cre treatment to ablate T-bet from primed Th1 cells to generate 
T-bet conditional knockout (CKO) cells so that we can more specifically investigate
requirements of T-bet in post-effector phase of memory T cell development. Th1 effector cells 
that were primed in vitro and treated with TAT-Cre without T-bet deletion were used as control 
(conditional wild type, CWT).  
We found that T-bet ablated Th1 cells maintained normal IFN-γ production while 
producing more IL-2. These results indicate that in short-term cell culture, T-bet is not required 
for the functional maintenance to produce IFN-γ. This can be explained by the epigenetic change 
in the Ifng locus, which results in the increased accessibility of the gene by transcriptional 
machinery. T-bet is involved in the chromatin remodeling of Ifng locus during Th1 
differentiation, resulting in the epigenetic change, especially histone acetylation (39). The pattern 
of histone acetylation can be propagated to progeny cells (129). Therefore, without the presence 
of T-bet, other transcriptional machinery can still bind to the open Ifng locus to promote gene 
transcription. T-bet ablated memory CD4+ T cells still maintained substantial levels of IFN-γ 
even though lower than the wild type cells, and they also produced more IL-2 than the wild type 
cells. Therefore, these data on one hand indicate that T-bet is required for optimal IFN-γ 
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production in the long run, on the other hand they suggest that there is a T-bet independent 
mechanism for IFN-γ in memory CD4+ T cells. NF-κB may be involved in the T-bet independent 
IFN-γ production because we previous showed that NF-κB was engaged in the immediate IFN-γ 
production during rapid recall of memory CD4+ T cells (206). Collectively, these data suggest 
that continuous T-bet presence is not required for effector cytokine production in Th1 effector 
CD4+ T cells but is required for optimal cytokine production in memory CD4+ T cells. The 
increased IL-2 production by T-bet-ablated CD4+ T cells indicate that T-bet is a repressor of IL-2 
production, which could be due to the roles of T-bet in interfering with NF-κB activities (212). 
Therefore, increased IL-2 production is likely related to increased NF-κB activities. Indeed, our 
transcriptome analysis results showed upregulatin of Nfkbid (IκBNS), which promotes NF-κB 
mediated IL-2 expression (213).   
We also assessed the effects of post-effector T-bet ablation in memory CD4+ T cell 
development. We found that CKO memory CD4+ T cells have better persistence compared with 
wild type cells when transferred to lymphocyte deficient RAG1/2-/- hosts or intact congenic 
hosts. Nonetheless, both CKO and CWT memory CD4+ T cells showed preferential lung 
localization and substantial TRM formation when transferred to RAG1/2-/- mice. However, when 
transferred to congenic hosts, both CKO and wild type CD4+ T cells had diminished TRM 
formation and showed no lung preferential localization. The difference in the lung environment 
between RAG1/2-/- and congenic mice may regulate the differential recruitment of effector CD4+ 
T cells to the lung. As RAG1/2-/- mice are lack of adaptive immunity, their lungs are under 
constant insults from foreign antigens, resulting in a pro-inflammatory environment in the lung. 
Congenic mice on the other hand have intact immune system and thus have non-inflamed lung 
environment. Therefore, the inflammatory lung environment in RAG1/2-/- hosts can recruit more 
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cells to the lung and promote TRM formation, indicating the importance of extrinsic 
environment in TRM formation.   
However, CKO memory CD4+ T cells showed preferential lung localization in greater 
extent and had more lung TRM formation compared with CWT memory CD4+ T cells, 
indicating there must be some cell intrinsic properties in CKO memory CD4+ T cells that result 
in the migration and localization pattern change. Our transcriptome analysis showed CKO CD4+ 
T cells had upregulation of chemokine receptor CCR4, which can promote cell migration to the 
lung. Greater functional plasticity of CKO memory CD4+ T cells may also be another factor 
regulating the migration and tissue residence. In vitro simulation showed that CKO memory 
CD4+ T cells had significant elevation of IL-17 production and RORγt expression. Our 
transcriptome analysis also showed that CKO memory CD4+ T cells had higher expression of IL-
17 and RORc, and they also upregulated Foxp3 and GATA3. These data suggest that CKO 
memory CD4+ T cells acquired abilities to express molecules that are expressed by different 
CD4+ T cell subsets. Therefore, CKO memory CD4+ T cells with greater functional plasticity 
may upregulate chemokine receptors expressed by different CD4+ effector subsets to facilitate 
their migration and tissue resident in the lung. Being skewed to Th17 type cells might also help 
preferential lung localization and TRM formation, since Th17 cells are shown to have potent 
tissue infiltration ability (216). Collectively, these data show cell extrinsic and intrinsic 
properties in regulating TRM formation.  
To determine whether lymphopenic conditions in RAG1/2-/- also promotes TRM 
formation, experiments using sublethally irradiated congenic hosts for CKO and CWT CD4+ T 
cell transfer are needed. Sublethal irradiation creates lymphopenic conditions similar to that in 
RAG1/2-/- mice. Therefore, if the increased TRM formation observed in RAG1/2-/- is due to 
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lymphopenic conditions of these mice, we are expected to see increased TRM formation in 
sublethally irradiated hosts. Nonetheless, since inflammation in RAG1/2-/- lungs may also recruit 
cells to the lung and enhance TRM formation, experiments using reagents to induce 
inflammation in the lung can help determine the roles of inflammation in TRM formation. 
PolyI:C can be used to induce inflammation in the lungs of  congenic hosts, followed by CKO 
and CWT cell transfer. Thus, if inflammation promotes the TRM formation in the lung, we are 
expected to more TRM formation in mice treated with PolyI:C.  
We also investigated the effects of early T-bet deletion from naïve CD4+ T cells in 
memory CD4+ T cells development. In our experiments using T-bet+/- OT-II and T-bet-/- OT-II 
cells, we showed that T-bet+/- OT-II cells had increased persistence while T-bet-/- OT-II cells had 
decreased persistence compared with wild type OT-II cells after PR8-OVA influenza infection. 
Previous studies showed that T-bet deficient cells had lower clonal expansion (115, 122). 
Therefore, T-bet-/- OT-II cells may have impaired T cell priming and differentiation resulting in 
decreased clonal expansion. As T-bet dosage also regulates the effector and memory cell fate 
(115), T-bet+/- OT-II cells with lower T-bet dosage may generate more memory precursors 
leading to better T cell persistence.   
However, our data showed that T-bet+/- and T-bet-/- OT-II cells had normal TRM 
formation as wild type OT-II cells. It has been shown that T-bet+/- CD8+ T cells had increased 
TRM formation due to enhanced integrin CD103 expression (176, 177). Unlike in CD8+ T cells, 
however, CD103 is not significantly expressed by CD4+ TRM cells. Therefore, CD4+ TRM 
tissue retention may rely on CD69, whose expression is independent of T-bet. That could be the 
reason that our data showed normal TRM formation in T-bet+/- and T-bet-/- OT-II cells as in wild 
type OT-II cells. It is also possible that strong inflammation in the lung during influenza 
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infection and strong affinity between OT-II cells and their ligand OVA peptides can overcome 
the differential T-bet expression and pull OT-II cells to TRM niche.  
The chemokine receptor CXCR3 is important for T cell trafficking. In our experiments of 
post-effector T-bet ablation and early T-bet genomic deletion, we found significant decrease of 
CXCR3 expression. However, CD4+ T cell localization and the capacity of TRM formation were 
not affected by the downregulation of CXCR3. The possible reason could be that CD4+ T cells 
also express other chemokine receptors to compensate the functions of CXCR3 for T cell 
trafficking. For lung TRM formation, many mechanisms are involved. It is possible that without 
the presence of CXCR3, expression of T-bet independent integrins can still facilitate T cell 
migration to the lung resident niche.  
Comparing our results between post-effector T-bet ablation and early T-bet genomic 
deletion, we found that the timing for T-bet expression is critical for CD4+ TRM formation. The 
differences in the experiment system can also result in the differential outcomes of TRM 
formation. However, there is one thing in common in these two systems, which is, lower T-bet 
expression promotes CD4+ T cell persistence. That could be due to the enhanced memory 
precursor formation by lower T-bet expression. However, T-bet-/- OT-II cells had decreased 
persistence, while T-betΔ/Δ effector CD4+ T cells had increased persistence in our post-effector 
T-bet ablation experiment. The discrepancy may result from the timing of T-bet deletion. T-bet-/-
OT-II cells have early T-bet deletion, which may lead to impaired cell priming and 
differentiation, resulting in decreased clonal expansion and persistence. However, T-betΔ/Δ 
effector CD4+ T cells have normal T-bet expression during priming, and post-effector T-bet 
ablation may increase memory precursor formation, resulting in increased persistence.   
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Collectively, our studies reveal roles of T-bet in the generation, function, homeostasis 
and tissue targeting of memory CD4+ T cells. We demonstrate the increased persistence, 
enhanced lung localization and TRM formation, and increased functional plasticity in T-bet-
ablated memory CD4+ T cells. We also show T-bet-ablated Th1 effector cells maintain intact 
effector cytokine production. Therefore, our work provide insights in the post-effector regulation 
of transcription factors in CD4+ T cell functional maintenance and memory T cell development.   
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